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G E N E R A L I N T R O D U C T I O N 
Malaria is still an important disease of the tropics. Despite the consider-
able achievements of malaria eradication in the past, still nearly 500 
million people are unprotected. Logistical, sociological, financial and 
technical problems interfere with the interruption of malaria transmission. 
Multidisciplinary research devoted to the bio-medical aspects of the vector-
parasite-host interrelationship is required to bring closer the goal of 
global malaria eradication. 
Some of these aspects can be elucidated by the study of malaria parasites 
in animal models, and it is often practicable to apply and extrapolate 
knowledge from such laboratory systems to the problem of human malaria. 
Even then, understanding of human malaria remains difficult, since four 
species of malaria parasites occur in man, and the course of the disease 
varies with each species. 
Roughly, the life cycle of these parasites, belonging to the genus Plasmodium, 
is as follows: different species infect various vertebrate hosts, including 
reptiles, birds and mammals. They all need an insect host for part of their 
development. Mammalian plasmodia require mosquitoes of the genus Anopheles 
as vectors. While infected mosquitoes bite, parasite stages called sporo-
zoites, are inoculated into the blood. Within one hour infective sporozoites 
disappear from the circulation, and in susceptible mammals they invade 
parenchymal cells of the liver. After intracellular replication as exo-
erythrocytic forms, newly formed merozoites are released into the blood, 
where they parasitize and multiply inside erythrocytes. Schizogony during 
the erythrocytic cycle initiates the known pathological effects such as 
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fever, anaemia and splenomegaly. Depending on the host-parasite system, a 
more or a less efficient immune response occurs after prolonged contact with 
these parasites. 
Various approaches exist for interrupting the life cycle of the parasite in 
its mosquito- and human host. Two main ways of interference are the control 
of the vector, and the use of antimalarial drugs. 
However, in large areas of the world even a combination of these methods 
cannot achieve eradication. It is doubtful if the extermination of parasites 
with such complex ways of life is attainable. In practice it appears impos-
sible, due to the resilient nature of the eco-system: many species of the 
mosquito vector have become resistant to promising insecticides, and Plas-
modia have developed resistance to otherwise highly effective drugs. 
These aspects have contributed to the general trend of a halt in the progress 
of malaria eradication programs over the past few years. 
Greater insight into the immune responses of vertebrate hosts appears to be 
a prerequisite for breaking this impasse, and may facilitate the production 
of more advanced and ecologically more acceptable control methods, such as 
vaccines. Knowledge of additional conditions for the production of vaccines 
is still very incomplete. Neither the cultivation of parasites, nor their 
biochemical analysis have been succesfully performed, nor do we know enough 
about the effective antigens. Hence the prospects for vaccination of man 
against malaria are still beyond our practical possibilities. 
Nevertheless, attempts to vaccinate laboratory animals and humans with non-
virulent, attenuated parasites have been made. Passages in vitro or through 
insusceptible hosts have been tried. Killed parasites, or fractions thereof 
have been used, but protection against virulent parasites has only been 
attained in exceptional cases. Recently, however, immunization with in vitro 
grown merozoites in adjuvant turned out to be an effective way of inducing 
protection in monkeys. 
Also the use of irradiation for attenuation of the parasites has appeared 
to be a promising approach. In a number of studies erythrocytic stages have 
been attenuated by irradiation, since it is these that are directly respon-
sible for the pathogenic effects of a normal infection. Again, consistent 
and reliable protection of animals against infection with virulent parasites 
appeared to be a difficult problem. 
Other stages of the parasite have also been used for attenuation. Evidence 
has been presented that irradiated sporozoites can be used as a vaccine. 
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During the past eight years Nussenzweig and her co-workers of the New York 
University Medical School, have made considerable progress in the demonstra-
tion and understanding of innate and acquired responses to single and re-
peated inoculations of mammalian plasmodial sporozoites. It was demonstrated 
that irradiated sporozoites elicit stage specific antibodies and that after 
repeated contact with these sporozoites, the hosts are completely protected 
against the development of parasitaemias following the administration of 
normal sporozoites. 
At present important questions concerning the role of antibodies, and lymphoid 
and phagocytic cells in the protective immune response are still incompletely 
solved. 
The main objective of the present study has been the collection of more data 
on the sporozoite- host interrelationship. The aim was to study the effect of 
repeated contact with normal sporozoites of a rodent Plasmodium in rats. 
Attention was paid to the decrease of susceptibility to infective sporozoites, 
after previous exposures to malaria parasites. 
A method for the assessment of sporozoite infectivity was applied, which 
gives more direct information than the techniques in common use. 
The study of the anti-sporozoite immune mechanisms is not very advanced yet, 
and results are still preliminary. Insight into the hosts responses to normal 
sporozoites may be of value for future progress in the production and applica-
tion of sporozoite vaccines, and for better comprehension of the epidemiology 
of malaria. 
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С II Λ Ρ Τ Г. R I 
ТИП PRE-ERYTHROCYTIC DEVELOPMENT ОГ Л MALARIA INFECTION 
1.1 The infection with sporozoites 
The strain of Plasmodium (Vinckeia) berghei Vincke & Lips 1948 used this 
study, was isolated in Zaïre, in a forest gallery near Lumumbashi in 1965 
by Vincke and Bafort. In 1968 some properties of this, so called Anka-
strain, were published (1). 
The local insect host is Anopheles dureni milleaampsi and the mammalian 
host is the ticket-rat, Grœmomys surdaster, also referred to as Tharmomys 
svpdasteT. 
Sporogony is obtained in laboratory-bred A. stephensi, when maintained at 
18-21 С (2). A variety of rodents are susceptible to blood-induced in­
fections, whereas white rats, hamsters, and, to a lesser extent, mice are 
susceptible to infection with sporozoites (3). 
Aspects of the pre-erythrocytic phase of P. berghei, are reviewed here, in 
order to facilitate the appreciation of the results presented in this 
study. Stages of the life cycle of the malaria parasite can be found in a 
variety of habitats: the mosquito, the liver and the blood of vertebrate hosts. 
That part of the life cycle which starts with the inoculation of sporo­
zoites into the vertebrate host and ends with the infection of erythro­
cytes, is described here as pre-erythrocytic development. Exo-erythrocytic 
forms (EEF) are those stages in the pre-erythrocytic development that 
parasitize liver parenchymal cells. The sporozoites in particular lead a 
variegated life. They are generated in the oocyst on the outer wall of the 
mosquito stomach and released into the haemocoel. From there, they move or 
are transported through the haemolymph to the salivary glands. They pene­
trate the secretory cells and enter the secretory mass, where they are 
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stored (A) and then have a mean length of about 12 μπι (5) . 
The sporozoites are released with the saliva of the mosquito. They are 
mobile, and this activity may attribute to the penetration of salivary 
glands in the mosquito and of liver parenchymal cells in the vertebrate 
host (6). Vanderberg recently established that sporozoites glide with their 
apical ends (=conoid) trailing when moving (7). 
The sporozoites are deposited intracutaneously or directly in the circula­
tion by the bite of the mosquito. Nothing is known of tissue reactions to 
sporozoites which stick in the subcutaneous tissue. It has been demonstrated 
by Beekman (8, 9), however, that the skin of an incompatible host (mouse) 
is a very effective barrier to sporozoites (P. gallinaceum). 
Those sporozoites that enter the circulation either by the bite of a mosqui-
to, or by artificial intravenous inoculation are exposed to phagocytic cells 
lining the bloodvessels. 1-2 hours after inoculation sporozoites can no 
longer be demonstrated in the circulation, as concluded from subinoculations 
of blood of infected volunteers (10). 
These short circulation times have also been found by Nussenzweig and co­
workers in an experimental system with A/J mice and P. berghei. Most of the 
sporozoites appeared to be cleared from the circulation within one hour (11). 
Since the blood is recirculating, they could pass the liver several times, 
and on one of these occasions they may succeed in penetration of the paren­
chymal cells. The processes of migration towards the liver, and of subsequent 
recognition, attachment and penetration have never been described. The spo­
rozoites that do not succeed in penetration are likely to be phagocytosed. 
An in vivo demonstration of such a process has never been given. Presumably 
the Kupffer cells of the liver and perhaps the spleen macrophages, are the 
main cells involved. 
When sporozoites have finally succeeded in penetrating parenchymal cells, 
they will start to develop into exo-erythrocytic forms (EEF). Maturation of 
this stage takes about 48 hours in P. berghei (4, 12), and at the end of 
this period the schizont has a diameter of about 40 ym. Estimations of the 
number of merozoites, produced in the liver of white rats, range from 
4000 - 8000 (4, 13). In Grarmomys these numbers may be twice, and in mice 
half as large (13). 
The schizogony inside liver parenchymal cells is followed by the liberation 
of formed merozoites, when the parasitized host cells are destroyed. Imme­
diately after this rupture the site is infiltrated by leucocytes. These 
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cells, which are mainly polymorphonuclear granulocytes and macrophages, 
phagocytose liberated merozoites. It is a wellknown fact that a considerable 
number of these merozoites are prevented from penetrating into erythrocytes 
(14). This should not be ignored in estimations of the number of erythro-
cyte-penetrating merozoites that originate from one sporozoite. 
1.2 Biological aspects of sporozoites 
Recently Vanderberg (6) clearly demonstrated that very few sporozoites from 
oocyts are infective (i.e. cause a parasitaemia in mice). Sporozoites ac-
quire infectivity when migrating via the haemocoel to reach the salivary 
glands. Maximal infectivity was observed in sporozoites that were stored for 
some days in the glands. Comparing immature stages from oocysts and mature 
stages from salivary glands, a 10.000-fold increase in infectivity was found. 
This increase appears to be time-dependent rather than site dependent. When 
sporozoites remain in mosquitoes for longer times they tend to loose their 
infectivity again. Infectivity of sporozoites also rapidly decreases when 
they are kept in vitro. 
Chilling the medium is favourable for the retention of infectivity, and the 
choice of the medium may also be important. Vanderberg demonstrated that 
serum albumin strongly preserves the infectious capacity of sporozoites, 
and that motility was also considerably increased (7). This correlates with 
the fact that blood is a natural habitat for sporozoites. 
In Vanderberg's studies infectivity was defined as the proportion of mice 
developing a parasitaemia, whereas the percentage of sporozoites which 
develop into mature exo-erythrocytic forms was defined as viability. 
A review of the literature on sporozoites reveals a confusing use of the 
terms viability and infectivity. Sometimes sporozoites are considered viable 
when they are motile, or capable of developing into EEF, or inducing a para-
sitaemia; on the other hand sporozoites are called infective, when they in-
vade liver parenchymal cells, with or without causing an erythrocytic infec~ 
tion. 
An in vitro test for the detection of their capacity to multiply is not 
available and in vivo estimates can be obtained only retrospectively. 
Therefore definitions should be strict, and accepted generally. Moreover 
they must reflect modern insights into the described properties and 
phenomena. 
With regard to the above mentioned definitions, it should be stated that a 
-6-
0) о
 
!
»
 
0)
 
О
 
Е
0 
о
«
 
>
 
о
 
ш
 
с
о
 
0) о о 
>
 
υ
 
О) 
с
 
О
 
с
 
CD
 
0) 
?
 «8 
й
 
>
 ¿ 
5
 
б
 
ω
 
la
l 
о
 
и
 
CD
 CD
 
О
 
IM
 
2 <υ E о с 
о
 
с
о
 
с
о
 
с
 
Щ
 
CD
 
"
σ
 g 
§
 
<
"
 
о
 
С
О
 
M
 
-b-
1 
ξ
Ο
 J
3
 
<D
 
^
 
=>
 
=>
 
с
о
 
О
 
с
-
с
 
cajú Q.
 
О) 
о
 
с
о
 
с
о
 
с
 
г
о
 
E χ
υ
 
г
-
 
*•
»
 
-
Г
Т
 
IT
I 
co 
u с о 
|S8'| 
о
З
 9
 
с
 E 
cö>-S?i
 E
 
¿JD
 ço£
 Q) 
k--0
 
С
О
ч
-
 
о
т
 
'S
 5
 s
 If 
¡
о
 
«
 
о
-£
 
О) 
£?
=
 
т
а
 
Ρ
 
г
о
 
>
 
0
 
і
_
 
>
.
с
 
Ç
 
о
 
о
 9
 
о
.
 
/гст
.
 
1.
 Sahenatia
 
presentation
 
of
 
the
 developm
ent
 
of
 
Plasm
odium
 in
 
the 
m
am
m
alian
 host,
 
w
ith
 
e
m
phasis
 
o
n
 the
 
v
a
rious
 
possibilities
 
of 
its
 
interruption
 
during
 
the
 pre-erythroaytic
 
stage. 
-7
-
parasitaemia is not necessarily a reflection of the properties of a sporo-
zoite, and by consequence it is only an indirect measure of the infectivity. 
On the other hand, when viability is defined as the capacity to develop into 
EEF, one must assume that sporozoites from the same source, failing to de-
velop into mature ELF in an unsusceptible host, should be considered non-
viable. Also immature sporozoites should generally be considered non-viable 
by this definition. It is hard to avoid the impression that this is a non-
functional approach. 
The following definitions are proposed and used throughout this study. 
Viable are those sporozoites that are apparently healthy, intact and motile, 
and supposedly capable of multiplication. 
Pending the development of methods for in vitro cultivation of the exo-
erythrocytic stage in cell lines, assessment of the viability is unattain-
able. 
Infective are those viable sporozoites that are able to develop into exo-
erythrocytic forms within (liver parenchymal) cells of a distinct host. 
In fig 1 some of the possibilities are depicted. 
Using these definitions, viability is considered a property of the organism, 
whereas infectivity is subject to a given host-parasite inter-relationship. 
Sporozoites in the salivary glands of a mosquito are thought to represent 
a variety of maturation stages (6), but also degenerating, non-viable spo-
rozoites might occur (6). Moreover, when an inoculum is transferred to a 
susceptible host via a mosquito bite or intravenous inoculation, apparently 
only a small and variable fraction of sporozoites actually develops into 
EEF (16). 
This means that, depending on the host's susceptibility, many viable but 
non-infective sporozoites are lost. The possible consequences of this are 
considered in sections 5.3 and 5.6. 
1.3 Immune responses to sporozoites 
1.3.1 Early attempts at irmunization with sporozoites 
The question concerning antigenic properties of sporozoites is not new. 
In 1936 Boyd and Kitchen (cited in 17) had wondered if the acquired homol-
ogous immunity to P. vivax was equally effective against sporozoites and 
trophozoites. They suggested that the sporozoite might be antigeni-
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cally different from the trophozoite, and that the immunity of the host 
might be directed mainly against the trophozoite rather than against the 
sporozoite. A more systematic study on the immunogenicity of sporozoites 
was initiated some years later by Mulligan, Russell and Mohan (18). They 
demonstrated that salivary gland sporozoites of P. gallinaoeum, P. malaviae 
and P. falciparum readily agglutinate in sera obtained during the chronic 
stages of homologous parasitaemias of sporozoite-induced infections. Con­
siderably weaker agglutination was found in sera obtained during accute 
stages of homologous parasitaemias of such infections and in sera from ani­
mals with heterologous parasitaemias. This agglutination was claimed to be 
a specific reaction though normal sera also agglutinated the sporozoites 
at low titre. Sera of trophozoite induced infections also agglutinated 
sporozoites at low titre. Apparently the reaction was not completely stage 
specific. They also found that, when sporozoites of P. gallinaceum were 
attenuated in ultraviolet light and repeatedly inoculated, sera of these 
chickens showed sporozoite agglutinating properties (19). 
Interestingly, parasite densities induced with non attenuated sporozoites 
were lower in such birds, and parasitaemias were less frequently lethal 
than trophozoite-induced parasitaemias. Fowls immunized with mixtures of 
many dried sporozoite containing thoraces invariably developed parasitaemias 
after being bitten by two infected mosquitoes, but percentages and mortality 
rates were lower than in controls. 
The immunized animals were not protected against infections with trophozoites. 
It was concluded that sporozoites elicit a clear specific immune response 
(10). 
Much later, however, Garnham and Bray (21) found that sporozoites of 
P. аупотоЪдг developed normally as EEF in monkeys, previously immunized by 
a sporozoite-induced infection. Numbers of EEF in these animals were re­
ported to be comparable with those in normal monkeys. 
Garnham (22) further stated that P. cynomolgi sporozoites, incubated in 
immune sera, were capable of developing into normal EEF and of inducing a 
parasitaemia. A third finding concerned the preservation of infectivity of 
sporozoites exposed in vivo to the blood of a sporozoite-immunized monkey 
and subinoculated into a non-immune monkey. 
These arguments led the author to state that sporozoites provoke no immune 
response, either because they are present in the circulation for too short 
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a time, or because the number of phagocytosed sporozoites is too small for 
providing a sufficient quantity of antigen to stimulate the production of 
antibodies. Further he failed to boost the inmune response with formalinized 
sporozoites in adjuvant, in a monkey that had previously been infected with 
sporozoites of P. a. bastianellii. 
After challenge, EEF of normal morphology were found in comparable numbers 
to those found in a control monkey. Sporozoites were found to agglutinate 
in serum of this immunized monkey. 
Garnham concludes that living sporozoites in a susceptible host are apparent­
ly non-antigenic, presumably because their antigenic components remain masked 
in liver parenchymal cells. He considered the non-viable sporozoites that are 
not able to penetrate liver parenchymal cells as the only possibility for 
anti-sporozoite responses. In our discussion on epidemiological consequences 
of antisporozoite immunity we shall come back to these conditions (see sec­
tion 5.6). 
At the same time Richards (23) repeated the experiments of Mulligan's group 
with sporozoites of P. gallinaoewn. He confirmed that three inoculations of 
dead or U.V. attenuated P. даЪЪіпасеът sporozoites into young chickens in­
duced high antibody titres in the sporozoite agglutination test. When 
challenged with viable sporozoites the animals survived subsequent low grade 
parasitaemias. U.V. and formalin treated sporozoites and dried sporozoites 
were highly immunogenic. Freeze-thawed sporozoites also induced partial pro­
tection in vivo, and agglutination in vitro to a lesser degree. Since then the 
P. gallinaaeum-chicken system has been abandoned in further studies on the 
anti-sporozoite immune response. Only recently was some work published on 
immunization with formalin killed merozoites from in vitro cultivated EEF of 
P. fallax of the turkey. A stage specific immune response was demonstrated 
which conveyed no protection against erythrocytic stages (24, 25). 
The promising approach of Richards has been applied in the mouse-P. berghei 
model by Nussenzweig. Together with her colleagues she greatly contributed 
to our knowledge of cyclical transmission of P. berghei in the laboratory 
(26, 27) and to the development of the exo-erythrocytic forms (28, 29). Ini­
tial attempts to immunize rodents with killed sporozoites were unsuccessful. 
It was discovered, however, that attenuation of sporozoites could be pro­
duced with specific doses of X-irradiation (30). 
These attenuated sporozoites could no longer cause a parasitaemia, and after 
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challenge with viable sporozoites, a number of animals were protected against 
parasitaemia. This discovery led to a long series of papers devoted to the 
subject of immunogenicity of sporozoites and the possibilities of using 
sporozoites as an anti-malaria vaccine. 
These studies, together with some additional results from others, are ex-
tensively reviewed under four successive headings. Firstly, the phenomenon 
of protection will be discussed, then the humoral factors involved, next 
attention will be given to non-specific factors of protection and finally 
alternative approaches will be considered. 
1.3.2 Sporozoite induced protection 
Mice that received a previous inoculation with irradiated sporozoites showed 
a variable length of the prepatent period (the time lapse between inocula-
tion and detection of the first circulating erythrocytic forms in blood 
smears after challenge with sporozoites). Animals developed either a delayed 
parasitaemia or no parasitaemia at all. This variation could not be standard-
ized, but, in a single experiment, the number of animals that developed no 
parasitaemia after challenge with non-attenuated sporozoites appeared to be 
dose dependent to some extent. With 5000 sporozoites more than half of the 
animals got a parasitaemia after challenge, whereas with 75000 sporozoites 
only about 1/4 of the mice became patent (30, 31). Further increase of this 
single immunizing dose did not enhance the number of protected animals (32). 
The degree of protection decreases from 100-0% within 2 months (32). Pro-
tection is defined by them as survival without parasitaemia. Thus only an 
all or none effect is measured. Partially protected are considered to be 
those animals that develop a delayed parasitaemia and consequently die. 
Despite this fatal course of parasitaemias of P. berghei in mice, the pro-
longed prepatent period is indicative of some anti-sporozoite immune re-
sponse. 
Protection is consistently enhanced when the number of inmunizing or booster 
inoculations with irradiated sporozoites is raised to 2-4, administered once 
or twice a week. But its degree varies. To obtain 100% protection it ap-
peared to be sufficient to use 4 boosters with considerably less sporozoites 
than the initial dose (initially 75.000, boosters 5000-20.000) (31, 33). 
Challenges of these immune animals (i.e. animals completely protected), 
even with large doses of non-attenuated sporozoites did not result in 
parasitaemia (34), as compared with non-immunized control mice. This state 
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of being protected remained intact for some months (33). X-irradiated, in-
fected mosquitoes can also induce a solid protection (37). Protection was 
best established by intravenous inoculations; intramuscular and intra-
cutaneous inoculations were less effective (32, 35, 36). 
In two out of several attempts, Nussenzweig succeeded in protecting rhesus 
monkeys, which had been immunized with multiple inoculations of large doses 
of irradiated sporozoites over a period of several months (53). Attempts at 
other laboratories were unsuccesful, probably due to insufficient numbers 
of sporozoites. At best a delayed prepatent period was found after chal-
lenge infections. This suggested that sporozoites, able to initiate tissue 
stages were reduced in number (39, 40). 
Some of several human volunteers immunized by bites of X-irradiated mos-
quitoes, infected with P. falaiparwn or P. vivax, did not develop a 
parasitaemia for months after repeated challenge with homologous sporo-
zoites (38, 41, 43). 
However, it is still not a simple matter to establish protection against 
parasitaemias in primates, using attenuated sporozoites as a vaccine (38, 53), 
X-irradiation has a clear effect on sporozoites. With 8000-10.000 rads no 
parasitaemias develop. However, at a dose of 8000 rads in one out of 11 
livers some partially developed EEF were found (44). This indicates that 
irradiated sporozoites are able to penetrate liver parenchymal cells. 
The infection is considered to be abortive. This single observation led to 
the hypothesis that attenuation does not necessarily abolish the penetration 
mechanism, nor the onset of multiplication. At lower doses of X-irradiation 
more retarded EEF are found in combination with prolonged prepatent periods 
(32). However, the viability of the inoculum is important; highly viable 
sporozoites need larger doses for attenuation (44). 
These results have been confirmed in monkey malaria. Warren and Garnhan 
(45,46) using X-irradiated sporozoites of P. cynomolgi, concluded that the 
development of EEF is influenced; the changes probably result from nuclear 
alterations. They also confirmed that the irradiation effects on development 
of EEF are dose dependent. A high dose of 10 krads resulted in no detectable 
EEF nor in a parasitaemia. Smaller doses initiated smaller EEF with few 
nuclei. Whether these were retarded or degenerative forms could not be 
established definitively. 
The spleen appears to play no key role in the protective response. 
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Extirpation after 5 immunizing doses and before challenge hardly reduced 
the number of protected animals and immunization of splenectomized mice 
still led to 60% protected animals at challenge (32, 36). 
Mice immunized with immature sporozoites (i.e. from oocysts or haemolymph) 
appeared not to be protected, when challenged with mature non attenuated 
salivary gland sporozoites (47). 
Sporozoite-immunized mice remained totally susceptible to challenge with 
erythrocytic stages (31) and gametocytes developing in these animals were 
infective to mosquitoes that subsequently developed infective sporozoites 
again (47). This means that ookinete formation was also unhampered. Moreover, 
there was no evidence of interference by anti-sporozoite-immune serum in vivo 
development and morphology of isolated EF.F, nor with the infectivity of 
originating primary merozoites (48). On the contrary active immunization 
with sporozoites or passive immunization with immune serum led to reduced 
numbers of EEF after challenge. The detectable EEF were smaller and less 
differentiated (49). 
After challenge with heterologous sporozoites (i.e. P. vinckei and 
P. chabaudi ) the immunized mice also appeared to be completely protected 
against these other rodent plasmodia (31, 33). 
After immunization with huge numbers of mosquito borne sporozoites of both 
species, one volunteer appeared to be protected for 3 months to several 
strains of P. falaipœnm but not to P. vivax. Conversely, when he was pro-
tected for 6 months to strains of P. vivax, he was susceptible for 
P. falciparum (38). 
1.3.3 Humoral factors in the antisporozoite response 
Vanderberg and his colleagues (49) described a new in vitro approach 
for the detection of specific antibodies. Viable sporozoites incubated in a 
suspension medium with immune serum develop a thread-like precipitate 
on one end. Endpoint titres for these precipitins could be determined by 
incubation in various dilutions. The reaction was called circum-sporozoite 
precipitation (CSP) reaction. 
The name is not quite adequate since the precipitate is not circum-
sporozoite in viable sporozoites, but it is generated at the terminal 
apical cup ("conoid). Only freeze-thawed sporozoites show a real circum-
sporozoite precipitate. Evenso, this name has been used for uniformity. 
The reaction is sporozoite specific, since it could not be demonstrated in 
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serum of animals with a history of blood-induced parasitaemias. It was pos-
tulated that this CSP correlated with protection, and thus could serve as an 
in vitro method of demonstrating protection (49). Therefore, much work has 
been done to elucidate the merits of this test. 
One intravenous immunizing dose with 75.000 irradiated sporozoites induces 
precipitates with non-irradiated sporozoites in sera, taken 35 weeks after 
inoculation. Larger doses initiate a more rapid appearance of CSP and result 
in higher titres (32). After a booster the CSP titre is detectable after 
7 days and rapidly reaches a given level. Further boosters increase this 
level, which remains constant for more than 3 months (32). CSP reactions 
occur independently of complement factor C3 and perhaps, also of CI and C2. 
But the reaction is apparently dependent on a cofactor present in immune as 
well as in normal serum. It is assumed that this serum factor stimulates 
antibody formation to the CSP antigen (32). 
Though technically difficult, more information about the mechanism of 
precipitates may be obtained by absorption of sera with intact or disrupted 
sporozoites (Kagan, in discussion 34). 
Intramuscular and intracutaneous inoculation also resulted in CSP reaction, 
but titres were lower than with intravenous inoculation. Sporozoites from 
oocysts produce very low CSP titres, those moving towards salivary glands 
produce higher titres, whereas salivary gland sporozoites give rise to the 
highest CSP titres. Heterologous rodent malaria sporozoites also form CSP 
after incubation in immune serum, but at lower titre than the homologous 
sporozoites (31). In monkeys and man, repeatedly inoculated with sporozoites 
of simian and human plasmodia respectively developed variable CSP antibody 
responses (38, 50). 
It has previously been demonstrated that sporozoites elicit clear anti-
body responses in incompatible hosts (51). Rats appear to be very good 
anti-sporozoite antibody producers. Immunization with simian or human sporo-
zoites to which rats are incompatible, nevertheless lead to strongly posi-
tive CSP reactions. However, positive reactions occur only with the homol-
ogous system, i.e. P. falaipaTum sporozoites showed no precipitate when in-
cubated with anti-sporozoite sera of other primate plasmodia and vice versa. 
Only cross-reactivity between sporozoites from different strains of the 
same species could be demonstrated. It was suggested that, due to the absence 
of cross-reactivity a possibility exists for distinguishing various species 
of sporozoites, for example in epidemiological studies (52, 53). 
-14-
This model of an anti-sporozoite immune response in an incompatible host 
has also been used to compare the antigenicity of the various developmental 
stages of sporozoites of simian Plasmodia. Again it was found that salivary 
gland sporozoites are more immunogenic than oocyst sporozoites with regard 
to CSP reactions (54). 
As stated above CSP reactions were at first thought to be indicative of 
protection, but CSP did not coincide with protection. After a single 
immunizing dose, some of the animals appeared to be protected after one 
week when challenged with non-attenuated sporozoites. 
But CSP titres could not be demonstrated until 3 weeks after that immunizing 
dose ( 32, 36, 55). Moreover, immunization with heat-inactivated or fraction-
ated, or irradiated sporozoites via the intraperitoneal route induced CSP 
antibody formation, but most of these animals appeared not to be protected. 
On the contrary, in animals immunized after splenectomy, virtually no CSP 
antibodies could be demonstrated, though 60% appeared to be protected. 
Recently it was found that immunization of thymectomized mice did not lead 
to protection, yet some CSP antibodies were demonstrable (56). 
It was suggested that the spleen is a major site for CSP antibody production, 
but this type of antibody is not protective. Nevertheless, the possibility 
cannot be excluded that they may play an additional role in the in vivo 
clearance of sporozoites in immune hosts. 
The circulation time of infective sporozoites has been used as an in vivo 
expression of anti-sporozoite activity. After intravenous inoculation of 
sporozoites blood samples were collected at regular intervals and sub-
inoculated into normal recipients. The later development of a parasitaemia 
in these recipients was thus a sign for the presence of infective circu-
lating sporozoites in the donor (57). After one hour apparently all in-
fective sporozoites had disappeared from the circulation of normal donors, 
thus confirming former data from the human model (10). However, in mice 
that had been immunized with irradiated sporozoites the circulation time 
of non-irradiated sporozoites was much shorter and took no longer than 
5-10 minutes. An accelerated clearance is thus taking place in immune ani-
mals. In mice that had received a passive transfer of immune serum, sporo-
zoites also disappeared more rapidly from the circulation than in animals 
with a transfer of normal serum, when these passively immunized mice were 
challenged with sporozoites. All of them developed a parasitaemia. 
The first erythrocytic stages were detected later than in controls, thus 
-15-
these animals could be considered only partially protected. Even repeated 
transfers of inmune serum fail to abolish infectivity of all sporozoites 
of a challenge inoculum (32, 34, 36). The observations indicated however, 
the probability of a humoral factor operating in the anti-sporozoite 
immune response. Protection was always partial. It means that other mecha-
nisms must be involved as well. 
Spitalny developed another method to detect humoral anti-sporozoite activity. 
Non-irradiated sporozoites were incubated in vitro in sera from immunized 
animals (33). After 45 minutes these sporozoites were inoculated into mice 
together with the incubation medium and the length of the prepatent period 
determined. Patency was generally delayed after incubation in immune serum. 
Thus the infectivity of these sporozoites was affected, and morphologically 
these sporozoites appeared to be altered. 
The serum factor was called sporozoite neutralization activity (SNA). No 
total neutralization was found after incubation for periods shorter than 
20 minutes. This was in agreement with the inactivation time indicated 
by in vivo clearance during circulation in the blood of immune animals (32). 
Seven days after a primary inoculation no SNA could be demonstrated in sera 
of those animals that were protected. After boosting, SNA was detected 
with increasing titre (up to 1:80 after 5 or more inoculations ). Heat in-
activation of the serum reduced this activity, which could not be restored 
by addition of whole complement. Moreover, complement factor C3 and the 
alternative pathway for complement activation were no prerequisites for SNA. 
Lysis of sporozoites is apparently not essential for neutralization and the 
antibodies involved may be heat labile. 
Participation of complement factors CI and C2 could not, however, be ex-
cluded as participating in neutralization activity. Since CSP could not be 
correlated with protection, the suitability of SNA as a parameter for 
protection was investigated. If SNA is an in vitro equivalent for protection 
its presence should coincide with protection, and without protection either 
no or low SNA should be detectable (32). 
With regard to the first stipulation it was shown that SNA becomes detectable 
in a way similar to that of CSP: a single dose of sporozoites, by which 
some of the animals are protected, is not followed by the detectability of 
SNA, but this readily occurs after a booster inoculation, with titres up to 
1:80. 
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Like CSP, detectable levels of SNA are not an essential component of pro-
tective immunity during the early stages of its development. Immunization 
with heat inactivated sporozoites induced CSP without protection, but hardly 
detectable titres of SNA. Animals that were protected despite splenectomy 
prior to immunization (60%), showed no CSP and had low SNA (32). Animals 
thymectomized before immunization, that were not protected, showed CSP but 
no SNA. After reconstitution with thymus cells, these animals again showed 
positive SNA. From these experiments it was concluded that some limited 
value can be placed on the SNA test as an in vitro indicator for the in vivo 
state of immunity (56). 
The data on protection and serology pointed towards an additional mechanism, 
involved in the anti-sporozoite response. Thymus dependent mechanisms might 
play a role, as was suggested by the results with thymectomized and recon-
stituted mice. However, transfer of cells from various organs of immunized 
mice generally conferred no protection to normal recipients (53). 
1.3.4 Non-specific anti-spoTozoite faators 
Since inocula of sporozoites from dissected salivary glands always contain 
contaminants of mosquito tissue and adherent microorganisms, it was thought 
that this debris might have an adjuvant effect (57). Repeated inoculation 
with salivary glands leads invariably to parasitaemia after sporozoite 
challenge. Before challenge these animals show no sign of CSP (49), nor do 
mice that were bitten by X-irradiated, but uninfected mosquitoes (47). 
In contrast, when mice are bitten on several occasions by X-irradiated in-
fected mosquitoes, they appear to be totally protected after intravenous 
challenge. By this way of immunization minimal contamination with mos-
quito antigen occurs (36). Eventual non-specific effects of mosquito de-
bris were extensively studied, since Alger et ai.(58) reported total pro-
tection of mice after intraperitoneal immunization with ground uninfected 
mosquitoes. Moreover, Nussenzweig had already established delayed patency 
and even protection after previous inoculation with Corynebacterium parvurn 
(59). Measurements through clearance of injected carbon, revealed a short 
increase of non-specific phagocytosis after inoculation of uninfected 
salivary gland suspensions. After an optimum on day 2, phagocytic activity 
decreased to normal levels. Booster inoculations of mosquito tissue further 
promoted the phagocytic response; each time the carbon clearance became 
normal. When inocula of salivary glands contained sporozoites, the phagocytic 
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activity was significantly increased. 
Spleen weights gave similar results. Unparasitized salivary glands induced 
a small increase after 2 days that could not be further increased with 
boosters. Inocula with irradiated sporozoites induced a more prominent in­
crease of spleen weight, which decreased to normal levels after one week. 
Boosters gave the same effect; only short lasting increases, without cumula­
tion. Also extirpation of the spleen reduced norvspecific phagocytosis. There 
is thus no correlation between protective immunity and stimulation of the 
mononuclear phagocyte system. However, it cannot be excluded that this stim­
ulation is important during the early stages of the anti-sporozoite response 
(57). In order to bypass these nonspecific factors in this immune response, 
the described purification technique of sporozoites, using density gradient 
centrifugation might be of value (60). 
1.3.5 Alternatives for X-irradiation 
Various treatments of sporozoites were compaired with X-irradiation. 
γ-irradiation gave comparable results to X-irradiation, but immunization 
with heated or freeze-thawed sporozoites induced less protection (32, 35). 
Alger and colleagues reported also some experiments with heat-inactivated 
and freeze-thawed P. berghei-sporozoites (58). After 6 intraperitoneal 
inoculations, challenge resulted in 80 - 90 per cent protection! However, 
non-infected salivary gland tissue also induced 50 - 70 per cent protection. 
Further data would be of use, since others could not confirm these results. 
Their examination of the treated sporozoites by electron-microscopy revealed 
that the freeze-thawed sporozoites had been completely disrupted, whereas 
heat-inactivated sporozoites were very like the control sporozoites. The 
authors suggest that, in view of the comparable immunization result, the 
sporozoite protective immunogen is of stable molecular composition, perhaps 
of membrane origin (61). 
Spitalny and Nussenzweig were not able to induce a high degree of protection 
with extracts of ultrasonicated or homogenized sporozoites, but CSF could 
be demonstrated in the serum of these animals (35). Young sporozoites from 
either oocysts or from the haemolymph that did not induce protection, led 
to CSP producing antibodies, but these precipitins were of another class to 
those specific for mature salivary gland sporozoites. Probably the antigens 
to which these antibodies are formed are functional in penetration of sali­
vary glands, and of liver parenchymal cells, respectively (48). 
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Some attention was given to the immunogenicity of non-irradiated sporozoites. 
One experiment has been described in which adult rats received a single dose 
of either irradiated or non-irradiated sporozoites. 
Longitudinally CSP reactions were determined. It appeared that titres of 
both groups rose after 20 days. Titres persisted in the rats that received 
irradiated sporozoites, but dropped to zero in the rats with non-irradiated 
sporozoites. From this result it was concluded that irradiated sporozoites 
are more immunogenic. This result was thought to be due to altered antigens, 
arrest of development, or fixation in other organs (32, 35, 36, 54). Booster 
inoculations with sporozoites induced high titres in both cases. 
Strangely enough some reviewers misinterpretated this finding and concluded 
that non-attenuated sporozoites are not immunogenic (62, 63). 
In the discussion (section 5.1) these results and conclusions are commented 
on in detail, because this single experiment has been an important encourage-
ment and challenge for the present study. 
In conclusion, we wholeheartedly agree with Nussenzweig's complaint that 
" there is a deeply rooted statement that sporozoites are not immunogenic ". 
The investigations of her group have convincingly demonstrated that sporo-
zoites are immunogenic, indeed, and that immunization with this stage in-
duces a solid protective response. 
The studies reported below confirm and extend these admirably performed 
investigations. 
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C H A P T E R II 
MATERIALS AND METHODS 
2.1 The choice of experimental animals 
Female Wistar rats (TNO Zeist, The Netherlands), 2-3 months old, were the 
main experimental hosts for the malaria parasite in this study. Their body 
weight was 150-200 gram and batches of rats varied at arrival less than 5% 
in individual weight. Generally guinea pigs were used for additional feeding 
to maintain a mosquito colony. Six to eight week old female Swiss mice (TNO, 
Zeist) were used for the daily infection of mosquitoes. This strain of 
Swiss mice is rather insusceptible to sporozoite induced infections in the 
sense that the number of developing EEF in the liver remains relatively low 
in comparison with other strains and species of host animals (1). Therefore 
Swiss mice are not the appropriate hosts for quantitative studies on the in-
fectivity and development of pre-erythrocytic stages. Л/J strain mice are 
more susceptible, but these aniñáis were not available in sufficient quanti-
ties. Young rats, however, exceed mice of the A/J strain in susceptibility 
to sporozoite induced infections (2). This determined the choice of the ex-
perimental animal. Inbred BIO.LP mice in which the thymus-deficiency factor 
(nude) was back crossed (TNO, Zeist) were used for immunization studies, to-
gether with normal littermates. Tree rats (Thamnomys sp) were obtained from 
Dr.I.Landau, Paris. They originated from the Central African Republic and 
are indicated as the Ippy-strain (3). All animals were housed under standard 
conditions in the Central Animal Laboratory of the Medical Faculty (head 
Dr.W.J.I. van der Gulden). 
2.2 Rearing of mosquitoes 
The development of Plasmodium berghei in their mosquito hosts requires the 
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fig. 2. View inside the reaping room. Newly emerged adult mosquitoes are 
aolleoted with a sucking machine containing a mosquito cage (right). 
fig, 3. Some accessories for mosquito-rearing : a bottle with cotton­
wool and glucose; a holding cage with wireframe and rubber band; 
a beaker for egg laying; an aspirator. 
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relatively low temperature of 18-21 С (4). Rearing of mosquitoes is optimal 
at higher temperatures. Therefore,two separate temperature and humidity con­
trolled rooms were in use. Anopheles stephensi was obtained through the 
courtesy of Dr.J.M.Bafort, Antwerp, and reared according to a technique, 
composed from various descriptions (5-8). The animals were maintained at 
27-28 С and 85% relative humidity, with a daily cycle of 12 hours of light and 
12 hours of darkness. Adults were fed 5% glucose solution. Females were 
allowed to feed biweekly on guinea pigs and laid their eggs after 2-4 days 
on filterpaper, put on a wet sponge in a shallow beaker. Eggs were put into 
rearing pans inside a floating paper square in order to prevent eggs from 
sticking to the inner walls of the pans and drying up by evaporation. Larvae 
were fed successively with hay infusion, yeast powder and a mixture of 
ground dog pellets (Hope farms) and cereal baby food (Bambix). Rearing pans 
were covered with a netting. Newly emerged adults were collected with a 
sucking machine and transferred directly to cages (fig. 2). 
2.3 Plasmodia! strain and infection of mosquitoes 
The strain of P. berghei (ΑΝΚΛ) was supplied by Dr.Bafort. It was kept in 
mice by weekly transfer of infected blood. After a maximum of 5 blood-
transfers the strain was cyclically transmitted. Several authors des­
cribed the optimal conditions for the cyclical transmission of this rodent 
parasite (2, 9-13). The infected animals and the infected mosquitoes were 
kept at 21 С and 85% relative humidity. Mice were used for infection of mos­
quitoes, three days after intraperitoneal inoculation of diluted infected 
blood (plm. 10 parasitized erythrocytes), when first erythrocytic forms, 
including gametocytes, were detectable in blood slides. 
This was done on 2 subsequent days per batch of mosquitoes. Mice were suit­
able for mosquito infection for about 4 days. After that time parasitaemias 
are high and though many gametocytes circulate in the blood, mosquitoes 
fail to become infected (11). The P. berghei infection in Swiss mice is 
lethal and most of the animals die within 7-10 days. 
The abdomen of inoculated mice was shaved, and in order to facilitate biting 
they were put into half cyclindrical perspex holding cages. The cages could 
be closed with a wireframe and fixed with a rubber band (fig. 3 and 4, design 
and construction by Mr.J.van Munster, Institute of Medical Parasitology). 
These cages have an important advantage over other devices in that one 
technician can easily immobilise animals for the feeding of mosquitoes 
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without the use of anaesthetics. There are also larger models for rats and 
guinea pigs. 
2.4 Harvest and inoculation of sporozoites 
Salivary glands of infected mosquitoes contain sporozoites about 14 days 
after taking the infective bloodmeal. At that time the percentage of positive 
mosquitoes was determined (generally approximating 100%) and the batch was 
used as soon as possible, i.e. 15-20 days after biting (10). Small numbers 
of mosquitoes were collected with a mouth aspirator (14). Before dissection 
legs and wings of the female mosquitoes were removed, under light chlorophorm 
anaesthesia, and the bodies were kept in a moist atmosphere to prevent pre-
mature death by dessication. 
Salivary glands of ten to twelve mosquitoes were dissected out into one drop 
of medium on a glass slide (9, 15). Perspex- and siliconized slides did not 
suit our purpose. The salivary glands were flushed into an all-glass homoge-
nizer placed in crushed ice, using a 2 ml syringe filled with chilled medium 
and fitted with a medium sized needle. Grace's Insect Tissue Culture medium 
(Gibco) with the pH adjusted to 7 was used as the dissection and suspension 
medium (16). Occasionally TC medium 199 (10) was also used. 
After dissection of the whole batch of mosquitoes the collected glands were 
homogenized and the suspension centrifuged for 3-5 min. at 700 r.p.m. (160 g) 
to remove the bulk of mosquito debris. 
The sediment usually contained 5-10% of the total sporozoite numbers, most 
of which could be separated from the debris by repeated grinding and centri-
fugation. Sporozoites in the supernatant were counted in a haemocytometer and 
adjusted to the required number per unit volume of medium. 
As calculated from 60 different suspensions the number of salivary gland 
sporozoites ranged between 15.000-35.000 with a mean of 25.000 per mosquito. 
Sporozoite suspensions were inoculated without delay into a tail vein of 
rodent hosts. Intravenous inoculation has been reported to ensure maximal in-
fections and induction of immune responses (2, 17, 18). 
Rats were lightly anaesthesized with aether and tails were soaked in warm 
water for exposure of the veins. 0,5 ml was inoculated per rat, and 0,1 ml 
per mouse. The whole procedure from dissection of one hundred mosquitoes to 
inoculation of twenty rats took about two and one half hours. Inoculations 
were done with assistance of one or two biotechnicians. 
The inocula were never standardized for exact numbers of sporozoites and a 
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comparable order of concentrations was considered satisfactory. However, 
control groups of untreated animals were always included. The effect of 
treatment in the experimental group was assessed on account of the control 
group. Experimental animals were injected with one or more sporozoite sus-
pensions, hereafter called inoculations or immunizing doses. The first im-
munizing dose contained about 150.000 sporozoites. whereas following "booster" 
inoculations contained about 50.000 sporozoites. This procedure of a large 
initial dose and smaller boosters was suggested previously (19, 20). The time-
lapse between immunizing doses was generally one week. The final inoculation, 
hereafter called the challenge, again contained higher doses of sporozoites, 
which was also administered to control animals. 
2.5 Parasitológica! examination of blood slides 
For the estimation of parasite densities, blood films were prepared from 
tail blood. After drying they were fixed in methanol and stained with a 
Giemsa dilution for 45 min. (9, 15). 
The Giemsa stock, solution was prepared as follows: 
Giemsa powder (Merck) 7,5 g in 650 ml of methanol and 350 ml of glycerol, 
shaken with glass beads for at least 48 hr. For use a 2,5% solution of 
Giemsa stock dilution was prepared in a buffer solution of 1,28 g Na.HPO,.IH^O 
and 0,72 g KH PO in 4 1 demineralized water (pH 7.2). 
In the smears 25 microscopic fields per smear were examined, each field with 
oil immersion objective containing approximately 250 erythrocytes. The number 
of parasitized cells was expressed per 10.000 erythrocytes. 
2.6 Histological procedures 
In this study density of exo-erythrocytic forms (EEF) was used as a measure 
for numbers of sporozoites that escaped natural and acquired immunity. Since 
the maturation time of EEF of the Anka strain of P. berghei. is about 48 hours 
(11, 21), autopsy or biopsy of the liver was carried out at 45 hours after 
inoculation. These were fixed in a modified Carnoy's solution (10 ml glacial 
acetic acid, 30 ml chloroform, 60 ml ethanol 96%)for 5 hours with a change 
of the fixative after 1 hour. The fixative was then replaced by ethanol 96%, 
which was also changed once. Pieces of liver were automatically passed in 
transit through acetone, methylbenzoate and toluene into a mixture of equal 
parts of paraffin and paraplast. 5 μιη sections were cut with a microtome, 
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fig. 4. A mouse in a holding cage with mosquitoes feeding on its shaven 
he l li'. 
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fig. 5. Rat liver tissue with three maturing EEF. 
and selected according to methods described below. 
The sections were mounted on slides with white gelatine (Merck) and after 
drying stained with the Giemsa-colophonium method (9, 15), as follows. Wax 
was removed from the sections by dipping the slides in xylene; subsequently 
the slides were dipped in alcohol and water. The tissue was stained in a 
mixture of 15 ml Giensa stock solution (see section 2.5) 10 ml acetone, 10 
ml methanol and 100 ml buffer. The same buffer was used as that for staining 
blood slides. For differentiation the slides were washed with tap water and, 
while still wet, rinsed with colophonium resin (15% solution in acetone) 
until green colour no longer came off. The colophonium was washed off with 
a mixture of 30% acetone and 70% xylene and the slides were placed in xylene 
before being mounted with Euparal. 
2.7 Processing of liver sections and counting of EEF 
If not stated otherwise the median lobe of the liver was processed and di­
vided into 3 pieces: one cut in line with the deep fissure, the other halving 
the bigger part. The 3 pieces were embedded together in paraffin wax, in an 
arbitrary sequence. Serial sections of 5 vim were prepared, and three of them 
(Л, В and C) selected as follows: after a first section A a ribbon of 10 
subsequent sections was discarded and a section В was chosen from the next 
5 sections (generally the middle one) for the third section С this procedure 
was repeated. This guaranteed a mutual distance between А, В and С 
of at least 50 um (50-90 ym). Since the maximal diameter of mature EEF in 
rats is up to 40 vim (11, 21), the same EEF could not be counted twice in 
these 3 sections. The total number of EEF were counted in the three slices 
of liver tissue on each slide А, В and С (9 slices). The procedure is de­
picted in fig. 6. Next the surface areas of tissue on slide В was determined 
by projecting this slide together with a point screen. The points within the 
tissue areas were counted (N) and used also as a reference for the tissue 
areas on slided A and С (fig. 7). 
2 
For conversion of the number of points to mm a conversion factor Ρ was 
determined by counting the number of points within the projected area of a 
coverglass of a measured surface. 
surface coverglass in mm 
surface coverglass in number of points 
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m.i_; 
liver lobes of a rat in situ 
r I right lobe 
ml median lobe 
11 left lobe 
с I caudal lobe 
median lobe 
one cutting line along the fissure 
and another halving the bigger part 
0 dû 
three parts embedded 
in wax ( paraffin and paraplast 1 1 ) 
Ò~0tf one section of Sjum with slices of Sparts 
Θ ρ ρ • ιζ 
Α • Β с 
selection of sections from ribbons 
A no! 
В no 14 (12-16) 
С no 30 (28-32) 
Ò S O microscopic slide with mounted section and 
cover glass 
fig. 6. Schematic presentation of the preparation of selected sections 
of liver tissue. 
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electronic register with countmgprobe 
fig. 7. Schematic presentation of the method to determine the surface 
area of slices of liver tissue. 
The surface area of l i v e r t i s s u e in s l i d e s А, В and С (S) was now c a l c u l a t e d 
as 
2 
S = S x N x P m m 
For a measure of density of EEF (M) the number of EEF on slides А, В and С 
2 
was determined and expressed per mm of liver tissue. 
number of EEF 
M ж 
S 
In addition, serial tissue sections were made of the median lobe and also 
of other parts of liver, for the study of EEF distribution and for the eval­
uation of the described measure used to assess EEF density (see chapter III). 
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2.8 Serological techniques 
2.8.1 Circumsporozoite precipitation (CSP). 
Qualitative determination of specific anti-sporozoite antibodies was per­
formed by Dr.G.L.Spitalny using the CSP reaction (22). In short, the pro­
cedure is as follows: Harvested sporozoites were mixed in a drop of serum 
on a microscopic slide and overlaid with a coverslip. The preparation was 
incubated for 30 min. at 37 С and 20 sporozoites examined for the character­
istically long precipitate. 
Serum samples were considered positive when at least 2 out of 20 sporozoites 
showed the CSP reaction. 
2.8.2 Sporozoite neutralization activity (SUA) 
This test was also performed by Dr.Spitalny, as described (20). 0,5 ml of 
pooled sera were mixed with 0,5 ml of a sporozoite suspension and incubated 
for 45 min at room temperature with vigorous shaking. After this time 0,1 ml 
of the mixture, containing 3.000 sporozoites was injected i.v. into normal 
A/J mice. Serum samples were considered to possess SNA, when no more than 3 
out of 7 recipients developed a parasitaemia, compared to 7 out of 7 of the 
controls. 
2.8.3 Interferon production 
In order to find out if after inoculation with sporozoites and with para­
sitized red blood cells interferon was produced, sera of inoculated rats 
were incubated on a tissue culture of rat embryo cells and subsequently the 
inhibition of plaque formation by vesicularstomatitis virus (VSV) was deter­
mined. For the assessment of interferon activity Wagner's plaque-inhibition 
method was used, as described by Jahiel et al. (23). The test as we used it 
needs improvement, and therefore, only the general procedure is given here. 
17-18 days old rat embryos were minced and incubated with a trypsin solution. 
Free cells were collected and grown at 37 С in enriched Hanks BSS. 
The cells were transferred to plastic Petri dishes (0 60 mm) and placed in 
a humidified CO. incubator at 37 C. The serum samples were diluted to 1:20 
and incubated with the monolayers of cells (two dishes per dilution). After 
5 hours of incubation and washing, the cells were incubated with an appro­
priate dilution of VSV, warranting about 100 plaques forming units (PFU) 
after absorbtion for 1 hour. Finally the VSV dilution was mixed with agar, 
containing neutral red. The plaques were counted after 48 hours. 
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As a control for the test some rats were injected intravenously with an 
artificial interferon inducer, a complex of polyriboinosinic and polyribo-
cytidylic acids (ri : rC), and diethyl-aminoethyl (DEAE) -dextran in PBS. 
The sera were collected by retro-orbital bleeding before inoculation, 2, A, 
8 hours afterwards, and twice on subsequent days. 
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C H A P T E R ITI 
ACCOUNT OF THF. ÎTTHOD FOR QUANTITATIVE CEF ASSESSMENT 
(in collaboration with Th.M. de Boo, 
Department of Statistical Consultation, 
University of NijmeRen) 
3.1 Introduction 
The length of the prepatent period can be used to obtain information about 
the infectivity of sporozoites in a host model system. This period begins 
at the moment of inoculation of sporozoites, continues with their migration 
to the liver, includes the time needed for the development of EEF in liver 
parenchymal cells, and then the subsequent liberation of liver merozoites in 
the blood. It ends when the first infected erythrocytes are detected in blood-
smears. Thus, the length of the prepatent period is the ultimate outcome of 
a complex series of events, and each of these is liable to alter with various 
influences. Therefore, the prepatent period, as a measure for infectivity, 
has important limitations. 
Another, more direct measure is the density of EEF in the liver. Earlier at-
tempts for this histological approach were made, but the determination of this 
density is laborious and statistical assumptions have to be made. None of these 
techniques are practical in experiments involving large numbers of animals, 
but the directness of the approach is attractive. Thus an attempt to develop 
a reliable method for the estimation of this parameter was made. In the follo-
wing sections the limitations and merits of this modified counting technique 
are evaluated and possible applications tested. 
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3.2 Statistical considerations 
3.2.1 Distribution of EEF in liver lobes 
At first sight the hypothesis of a uniform distribution of EEF throughout 
an infected liver or liver lobe seems acceptable. To test this hypothesis, 
median lobes of sporozoite-infected animals, inoculated on different occasions, 
were completely sectioned. Slices were selected at mutual intervals, with a 
distance of + 75 um. If a uniform distribution existed, the numbers of EEF per 
2 
slice would follow a Poisson distribution. Α χ test (1) was used to check the 
validity of this hypothesis, (a • 0,05; table 3.2.1). 
Table 3. 
Rat 
A 
В 
С 
.2.1 
part of 
median lobe 
a 
b 
с 
a 
b 
с 
a 
b 
с 
hypothesis of uniform 
distribution 
not rejected 
rejected (p< 0.025) 
not rejected 
rejected (p<0.005) 
rejected (p<0.005) 
rejected (p<0.005) 
not rejected 
not rejected 
not rejected 
M 
0.024 
0.024 
0.021 
0.287 
0.386 
0.311 
0.041 
0.041 
0.034 
The data show that a uniform distribution could not always be demonstrated. 
Among other things, this was owing to technical factors in preparing histolog­
ical sections. Serial sections through a liver lobe should show a gradual 
change in the size of their surface areas, since they follow the natural shape 
of this lobe. 
Instead of a gradual change in size, irregularities were sometimes found. 
The possibility was considered that the source of this variation may have 
been due to attaching freshly cut sections to glass slides with warmed gelatin 
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adhesive, and thus stretching the sections on the slides. This would directly 
influence the surface size of the tissue. Even if this fact was accounted 
for, other unexplained differences remained. Thus, it was concluded that al­
though a uniform distribution of EEF may occur in the median lobe with low 
densities of EEF, this could not be assumed generally. Therefore, the results 
obtained by the counting method used, were assessed irrespective of a speci­
fic distribution of EEF through the median liver lobe. 
3.2.2 Properties of M (relative EEF density) 
2 
As stated in section 2.7, M is the number of EEF/mm of liver tissue surface. 
It is used as a measure for comparing EEF densities in the livers of indi­
vidual rats. It also provides a relative measure for the infectivity of the 
batch of sporozoites used. An account is given of the properties of M. 
It is impossible to cut each median lobe into three parts exactly along the 
along the same lines (see fig. 6). Therefore, define a region of about 
2 mm on both sides of theoretical perpendicular cutting-planes. This 
region is large enough to contain all possible realisations (sections). The 
actual sections can then be considered as a random sample from the popula­
tion of sections in this region. Consequently, M is stochastically distri­
buted over this region. However, only the distribution of H over a given 
population of rats is of interest, if a comparison of two or more popula­
tions is wanted. Let this distribution for population i be denoted by F., 
its mean by y. and its variance by σ .. If a rat is randomly chosen from 
population i, sections taken as described above and M. computed, then the 
sources of variation in It. are: 
1 2 
1) Biological variation between rats of populatiijn i, σ , . 
2) Variation caused by sampling from the liver region defined above, σ 
2 
3) Variation caused by shortcomings in the experimental procedure, σ 
These three variances are mutually independent, so they may be added; 
2 2 2 2 
the sum of them gives just σ . = σ , . + σ . + σ 
ft J
 ι bi π ei 
An assumption has to be made as a result of the circumstance that a sample 
of sections is taken from an anatomically defined region, instead of being 
taken at random from the whole liver. Since the value of M has to be re­
presentative for the EEF density in the whole liver, density in the defined 
region should be a monotonically increasing function of the density in the 
whole liver. If, for example, the decision would be to accept the hypothesis: 
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μ. > μ. (i.e. the mean of population i is greater than that of population j), 
then acceptance of the given assumption implies that animals from population 
i have a higher density of EEF in their livers than those of population j, 
which is what is required. The given assumption seems to be a natural one. 
It is impossible to prove that it is always true, but an illustration of its 
correctness is given in the following: 
From each of the four lobes of 17 rats (from 3 experiments) 3 sections were 
taken as described in chapter II. In the median lobe they were taken from the 
defined region, in the other lobes they were selected at random. The EEF densi­
ty for each of the lobes was determined. The mean, say D, of these four values 
is then an estimator for the mean EEF density in the whole liver. Thus, there 
were 17 different D-values, ranging from 0.09 to 1.9. Now the assumption im­
plies that M is a monotonically increasing function of D. To verify this, the 
correlation coefficient between M and D was computed. This proved to be 0.996, 
which implies that the relation between M and D is positive and almost linear. 
The regression-equation was M=0.017 + 1.042 D, which shows that (for the given 
animals, in the given range) the value of M is a bit larger than the mean 
value D (see also section 3.2.5). 
3.2.3 Tests of hypotheses 
The aim of many of the following experiments is the comparison of 2 or more 
groups of rats, drawn at random from different populations. Therefore, it 
was necessary to know the distribution of M for those populations. 
It appears that this distribution depends on the population from which the 
sample of rats was drawn. For instance, if a group of rats is almost complete­
ly immunized, the distribution of M will approach the limiting distribution 
P(M=0)=1, because in that case there are hardly any or no EEF left in the 
liver. On the other hand it could be that the normal distribution is a fairly 
good approximation, if the population from which the rats are drawn consists 
of heavily infected rats. Between these two extremes, many mixed distribu­
tions are possible. To avoid this multitude of unknown distributions, 
distribution-free methods were used. Where a comparison between two samples, 
drawn from populations i and j was wanted Wilcoxon's test (2) was used. 
The null hypothesis is H ; F. = F., in other words, the distribution of M. 
and M. are equal. If H is rejected then, strictly speaking, the only con­
clusion can be that F. У F.. It is, however, justified to extend 
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this conclusion to μ. 4 P.. if one of the distributions approaches the 
ι j * 
above-mentioned limiting distribution; if neither of the distributions 
approaches the limiting one and both (sample) variances are not too different, 
the assumption is, that we are dealing with two equal, but translated dis­
tributions. 
It often occurred that in one sample a large group of equal observations ap­
peared (e.g. several null-values). In such cases a correction should be ap­
plied to the test-statistic of Wilcoxon. This, however, was never done, but 
in not doing this, the computed tail-probabilities (p-values) are usually 
conservatively compared with the real p-values and consequently our con­
clusions are rather more than less safe. 
Finally, it should be noted that,in most cases,it was impossible to construct 
confidence intervals for μ. - μ. on account of the dissimilarity of F. and 
ι j ι 
F.. 
J 
If more than two groups had to be compared, there were two possibilities: 
that the sample sizes were either unequal or equal· In the first case 
Wilcoxon's test was repeatedly used for each comparison. In the latter case 
Steel's test was used (3). All the following tests had a=0.05 unless other­
wise stated. If the name of the test is not given then Wilcoxon's test was 
used; in all the tests the p-values are given. 
In order to give a quantitative impression of differences in EEF densities 
the mean of the sample from population i was also expressed as a percentage 
of the mean in the other sample from population j (generally that of the con­
trol group). It should be stressed that such percentages only relate to the 
samples and do not give exact information of the magnitude of the differences 
between the populations. Thus, the values of these percentages is limited. 
3.2.4 The number of slices per liver and the number of animals per· group 
In the normal routine 3 x 3 slices of liver per animal were examined for the 
determination of M. as an estimator for μ.. It is not simple to find out 
ι ι 
which number of slices would give an acceptable approximation of μ. . The 
accuracy of M. as indicated before (see section 3.2.2), is disturbed by three 
sources of variation. The probability that M. approximates μ., increases 
when more rats are included per group, when more slices are examined per 
animal and when technical failures are minimal. 
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To Ret some insight into the significance of the differences between the 
2 2 
variances σ , . and σ ., consider the followine as an illustration. 
bi π " 2 2 
It is assumed that for the below mentioned rats the variance σ . = σ 
2 e i e 
We may divide σ into two parts, one of which is added to the biological 
variance σ , . and the other to the reeion-samplinp variance σ 
bi " ri 
The first part could be called the "induced biolopical variance" and con­
tains the variance caused by such technical errors as for instance unsuccess­
ful injection. The latter could be called the "induced region-samplinß variance" 
and contains the variance caused by errors such as compressing and stretching 
of tissue slices. The notations: σ , . and σ . will not be chaneed. 
bi π ь 
Л piece of liver from the defined region in the median lobe of one rat was 
cut into 50 serial sections and numbered from 1 to 50· 
To compute M, there are 26 trios of sections available, e.g. {1, 13, 25}, 
{2, 14, 26}, ...j {26, 38, 50}. In the normal procedure, a trio was selected 
at random. Thus, the variance of these 26 M-values is an estimator, say s , 
2 2 _ 8
 r 
for α ( s 7881 χ 10 ). The mean of the M-values was 0.068. 
г r 2 2 
In order to compare σ with σ , , it seemed logical to use for comparison 
those groups (samples), whose mean M did not deviate too much from 0.068. 
As a result, 17 groups from the following experiments were used with M 
ranging from 0.048 to 0.088. 
the experiments: 4.1.3. С 4.1.10. С 4.2.7. E2 
(chapter IV) 4.1 
4.1 
4.1 
4.1 
1.4. С 
1.7A El 
Ι.7Λ CI 
I.7B E2 
4 . 2 . 3 
4 . 2 . 5 . 
4 . 2 . 5 . 
4 . 2 . 6 . 
4 . 2 . 7 . 
E 
Cl 
C2 
C4 
El 
4 . 2 . 8 . 
4 . 3 . 2 . 
4 . 3 . 3 . 
4 . 3 . 4 . 
4 . 3 . 5 . 
E 
С 
С 
Ρ 
Ρ 
2 
J . 
1 
analyze statistically, the following assumptions are made: 
For each of these groups the estimation s . of σ  is known. To be able to 
1) The above mentioned set of 26 M-values is a sample, drawn from a normal 
distribution. Also the 17 groups are samples from normal populations. 
2 
2) The region-sampling variances σ . are equal for all the populations i 
Γ 1
 2 
(i « 1, 2,.., 17) and equal to σ . 
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re 1: Even if this is not the case, then the actual distributions are prob­
ably reasonably well approximated by normal distributions. 
re 2: This assumption seems feasible. 2 2 
s ./σ . 
With assumption 1 the stochastic variable — =— has the F-distribution 
I 
with v. = n. - 1 (n. is the number of - r r rats in croup i) and 
1 1 1 H I - ' 
25 degrees of freedom. 2 2 2 2 
σ . σ . + σ
 σ
>,· 
The consequence of assumption 2 is, that —-— = = = 1 + — « — 
σ σ σ 
г г г 
Mow we are able to construct 95% - one sided confidence intervals for the 
2 2 
ratio σ . ./σ , as follows: bi r 
2 2 2 2 
P É r - p r < F0.95> = 0 · 9 5 = ^ > ( F 0 . 9 5 * ^ " ' i 
2 2 
_ P ( , • І Ь І >
 ( Р О < 9 5 , ! _ £ ) - > ) 
σ s . 
г - ι 
2 2 
= Ρ ( 1 ϋ > ( р
о < 9 5 Х І £ ) - · . ,) 
σ s . 
r - 1 
2 2 - 1 
If a. = (F
n
 „. χ s /s .) - I, then the 17 confidence intervals are thus 
-1 0.95 - r - ι 2 2 
determined by: Ρ(σ ,./σ > a.) = 0.95 for i = 1 17. 
The 17 computed values for a. are (smallest to largest): 
0.84; 1.78; 2.06; 2.84; 3.32; 4.73; 4.97; 5.14; 5.30; 5.71; 5.83; 7.68; 
8.53; 14.98; 17.14; 18.76; 23.12. 
From these results it can be seen that, in Renerai, the biological variance 
is (much) greater than the region-sampling variance: even when the largest 
2 
values are disregarded, a , is (generally) at least 4 to 5 times as large 
as σ 
r 
With sone caution it might be stated that a similar effect will probably be 
apparent with other (not too small) values of M. 
These and some other considerations were made using already available data 
obtained by the described method of sampling. 
From all this it appears that not much is gained by taking more than, say, 
3 x 3 slices per animal, at considerable expense of labour. Thus the number 
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of 9 was used in all experiments. Much more information would be gained by 
increasing the number of animals per group. This number, however, is res-
tricted by experimental circumstances; 7 or 8 animals were used in most 
cases. 
3.2.5 Densities of EEF in other liver lobes 
The question of densities in other lobes of the liver was intriguing, though 
knowledge of this point was not necessary for this study, in which only median 
lobes were used for the assessment of EEF density. 
But, as stated before, the number of EEF found per given surface area of liver 
tissue, cannot be generalized for the other lobes. The four lobes of a liver 
are anatomically different, making it impossible to prepare sections from com-
parable regions. Therefore, the M of the median lobe is incomparable with the 
values found in other lobes. However, there is a way to compare the densities 
in the 4 lobes in general, and that is to take sections at random from each of 
the lobes. This was done with four infected rats, by examining 10 sections of 
3 slices each, taken at random from the four lobes. For each of the rats the 
hypothesis was tested that there was no difference in EEF density between the 
lobes (with one-way analysis of variance). In none of the cases (with densi-
ties ranging from 0.12-0.32) the hypothesis was rejected (p<0.50 for all of 
them), which implies that no significant difference could be demonstrated. 
Another question that one may ask, is, whether or not there exists a systema-
tic higher (or lower) EEF density in one lobe than in the others (although, 
as we saw, the actual differences for these 4 rats are not significant). 
Using Friedman's test (3) it was found that no such indication existed (p>0.10). 
However, remembering the outcome of the regression equation in section 3.2.2, 
the same test was applied to the there-mentioned 17 rats. In this case, a 
slight indication was found (0.05<p<0.10) that the density of the median lobe 
was systematically higher than that of the caudal lobe. 
The values of the other lobes lay in-between. ' 
The point was not further investigated. 
3.2.6 The limited sensitivity of the counting method 
It was mentioned that under certain circumstances the number of EEF in the 
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liver might approach zero, i.e. no EEF being demonstrated with the counting 
technique. 
Indications for subdetectable EEF can be found by two methods. The first 
includes the complete sectioning of the liver, which is very laborious. 
Therefore an approach was made by sectioning the complete median lobe of a 
rat in which no EEF had been found with the routine method, the rat was taken 
from a group where the other animals had shown detectable numbers of EEF. In 
53 sections (3x53=159 slices) at mutual distances of 75 ym, a total of 4 EEF 
could be detected. This indicates, qualitatively, that the counting technique 
has its limitations. The other method is by performing biopsies while keeping 
tha animals alive, to allow the eventual development of parasitaemias. Even 
if EEF were not detected, erythrocytic stages might appear. This method also 
gives a qualitative assessment of the sensitivity of this counting method. 
Not withstanding these limitations in the sensitivity of the counting method, 
difference between populations could be readily detected by a statistical ana-
lysis. In these studies this property was used to demonstrate mechanisms that 
interfere with EEF development. 
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3.3. Application of the counting method 
3.3.1 Dose of spovozoites. 
To investigate the relationship between numbers of inoculated sporozoites 
and densities of EEF different dilutions of a suspension were inoculated 
into groups of two month old rats. Results are given in table 3.3.1, (exp. 
1Λ). 
The correlation coefficient r between the dose of sporozoites and the number 
2 
of EEF per mm of surface was 0,83. 
This experiment was repeated with dilutions of another sporozoite suspension. 
A correlation of r= 0,94 was found. Data of both experiments are given in 
figure 8. It can be seen that in both experiments a higher dose results 
in a higher density of EEF, within the range of the given doses. Regression 
lines can be constructed through these points; the relationship between dose 
and density is not necessarily linear, however, especially not in doses which 
fail to induce detectable densities in all animals (exp. IB). 
From the figure it becomes clear that both regression lines are not iden­
tical, implying that results from different experiments cannot be compared. 
This was confirmed by the attempt to compare numbers of mature EEF of 21 in­
dependent sporozoite inoculations. The variable sporozoite doses were plotted 
2 
against the numbers of EEF per mm of liver tissue (fig. 9). 
In this case a correlation coefficient r=0,51 was found. It means that the 
correlation between doses of sporozoites from different batches and densities 
of EEF is very weak. It can be seen that a high dose from one batch does not 
necessarily result in a high EEF density. Thus the density resulting from a 
sporozoite dose of another batch of mosquitoes cannot be predicted. 
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Table 3.3.1 
Exp. IA inoculated sporozoites 
125.000 67.500 34.400 17.000 
M 
s . d . 
0 , 1 3 
0 , 1 9 
0 ,21 
0 ,25 
0 , 4 3 
0 , 2 4 
0 , 1 1 
0 ,11 
0 , 1 3 
0 , 1 3 
0 ,14 
0 ,18 
0 ,19 
0 ,15 
0 , 0 3 
0 , 0 2 
0 , 0 6 
0 ,07 
0 , 0 8 
0 , 0 8 
0 , 1 8 
0 , 0 6 
0 ,02 
0 ,02 
0 ,02 
0 ,04 
0 ,04 
0 , 0 4 
0 , 0 6 
0 , 0 4 
0 , 0 1 
Exp. IB 
inoculated sporozoites 
300.000 215.000 107.000 27.000 7000 
0,214 0,102 0,026 0,0 0,0 
0,248 0,103 0,026 0,004 0,0 
0,272 0,148 0,051 0,004 0,0 
0,313 0,199 0,057 0,018 0,007 
M 0,262 0,138 0,040 0,006 0,002 
s.d. 0,042 0,046 0,016 (0,008) (0,004) 
R 0,0-0,018 0,0-0,007 
4 
2 
In this and the following tables the values of M (number of EEF/iran of liver 
tissue), the mean value M and the standard deviation s.d. are given. When 
s.d. < M, the range R is also given. 
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fig. 8. The relationship between nmbere of sporozoites from one batch 
of mosquitoes, and resulting EEF densities. Upper graph exp. 1Л, 
lower graph exp. IB. 
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fin. 9. The relationship between nunbers of sporozoites fror different 
batches of nosquitoes, and resulting EEF densities. 
3.3.2 Preservation of infective sporozoites in vitro 
Sporozoites tend to loose their infectivity rapidly in vitro. Since it takes 
at least two hours to dissect a hundred mosquitoes, and to prepare and inocu­
late the sporozoite suspension, a medium is needed which preserves their 
infectivity. In a small experiment (2Λ), we tried to assess the influence of 
delayed inoculation, and preservation in vitro at A in two media: M199 and 
Grace's insect TC medium. Rats received 120.000 sporozoites, suspended in 
one of these media, directly after preparation and after one and two hours. 
The resulting numbers of EEF (table 3.3.2) with Grace's TC medium tend to be 
somewhat higher than those with Ì1199, which may indicate a better preserva-
tive effect of Grace's medium on sporozoites. The influence of time on the· 
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Table 3.3.2 
Exp. 2Λ tine 
Ïnocc 
of 
ilation 
(hours) 
0 
1 
2 
Cîrace 
0,20 
0,11 
0,21 
0,16 
0,14 
0,10 
M 19' 
0,13 
0,10 
0,08 
0,06 
0,07 
0,05 
Exp. 215 
original Grace original Grace 
pH6, directly pH6, inoculated 
inoculated after 90 min. 
0,16 0,02 
0,18 0,06 
0,21 0,12 
0,21 0,12 
0,21 0,12 
0,24 0,15 
0,28 0,17 
0,28 0,20 
M 0,22 0,12 
sd 0,03 0,05 
Grace 
inoc. 
0,04 
0,13 
0,14 
0,16 
0,19 
0,22 
0,24 
0,29 
0,17 
0,07 
pH7 
90 min. 
Grace plI7 
10% calve serum 
inoc. 90 min. 
0,16 
0,18 
0,18 
0,18 
0,19 
0,22 
0,23 
0,23 
0,19 
0,02 
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loss of infectivity of sporozoites kept in Grace's insect TC medium and in 
modifications of it was investigated (exp. 2R). 
Λ sporozoite suspension was divided into 4 parts. Two parts remained untreated, 
to the third part 10% calve serum was added and the acidity of this and the 
fourth part adjusted to pll 7. Volumes and numbers of sporozoites of the four 
parts were equal. One of the untreated batches was inoculated immediately 
after preparation (i.e. 2 hours after start of dissection). The three other 
batches were inoculated 90 minutes thereafter. 
Using Steel's test, differences between the four groups were investigated. 
The results of both untreated batches differed significantly (p<0,05), so 
did those of the second untreated batch (90 minutes), and the batch adjusted 
to pH 7 with additional serum. 
This indicates that the infectivity of sporozoites in unmodified Grace's 
medium (pH 6) is relatively badly preserved. pH 7 and additional serum pre­
vent the sporozoites from significant loss of infectivity during a time lapse 
of II hour. In further studies the pH was adjusted to 7, to preserve infecti­
vity during the dissection and preparation of the sporozoites suspension. 
Serum has generally not been used, to avoid the danger of serum sickness. 
3.3.3 Influenae of species and age on susceptibility to sporozoites 
Initially 6-8 weeks old Swiss mice were used in experiments. 
It appeared, however, that mice are very unsuitable hosts for sporozoites: 
mice got (lethal) parasitaemias, but prior numbers of EEF were very low. 
В 10. LP and Л/J mice were also tested. Only the A/J mice were more susceptible 
to sporozoites than the Swiss strain, but could not be obtained in large num­
bers. Moreover in Wistar rats better results were consistently obtained. About 
20 times more EEF were found in two months old rats than in Swiss mice, when 
inoculated according to their body weight. But in contrast to mice there are 
indications that susceptibility in rats diminishes with age. The ultimate 
effect of these variable influences was compared, including those on the tree 
rat (Tharmomys sp.). The results are summarized in table 3.3.3. 
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Table 3.3.3. 
Experinental Mean body-
animals number weight 
4 month rats 5 230 β 
2 month rats 3 125 g 
Tharmomys 3 40 p, 
Swiss mice 5 23 g 
sporozoite 
inoculum 
1.00 ml 
0,55 ml 
0,18 
0,10 ml 
EEF/mm liver 
0,20 + 0,11 
0,40 + 0,14 
0,21 + 0,15 
0,003 + 0,005 
From these results it was concluded that rats are relatively susceptible 
hosts for pre-erythrocytic stages of P. berghei, and that young adult rats 
especially show high densities of mature EEF. Clear differences between the 
means of the young rats and those of tree rats were not found. 
3.3.4 Causal prophylaetic effect of chloroquine 
In the studies presented in chapter 4.1. the effect of the immunogenic 
capacity of sporozoites had to be distinguished from effects caused by the 
erythrocytic stages developing from nature EEF of previous sporozoite in­
ocula. Since there are practically no quantitative data on the influence 
of a parasitaemia, or its subsequent immune response on the course of re-
inoculation with sporozoites, chloroquine was used to suppress the deve­
lopment of parasitaemias. Though there are no indications in the literature 
that suggest a causal prophylactic effect of chloroquine, the influence of 
the drug was tested several times by its addition to drinkingwater. A re­
presentative experiment is described: a group of ten young rats received 
chloroquine in their drinkingwater over ten days (Nivaquine, 1,0 ml/1). 
Following these ten days sporozoites were inoculated (250.000/rat), while 
chloroquine treatment continued. Results from this treated group and a con­
trol group, both consisting of 10 rats, showed no difference (p=0,4Jtable 3.3.4), 
Hence chloroquine was used in experimental and control groups in immunization 
studies. 
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Table 3.3.4 (chloroquine) (control) 
0,050 
0,162 
0,168 
0,239 
0,249 
0,273 
0,292 
0,323 
0,332 
0,429 
M 
sd 
0,065 
0,168 
0,184 
0,200 
0,222 
0,267 
0,315 
0,340 
0,433 
0,504 
0,270 
0,131 
0,252 
0,105 
3.4 Conclusions 
a ) Generally,the hypothesis of a uniform distribution of EEF in the me-
dian lobe had to be rejected. The true distribution was not investigated, 
since it was not considered important for the evaluation of results. 
b ) EEF densities were indicated as follows. Numbers of EEF in 9 slices 
of liver tissue from a defined region of the median lobe were expressed per 
surface area of the tissue slices. It was assumed that densities in defined 
regions of the median lobes, are a monotonically increasing function of the 
densities in the livers. 
c) The sensitivity of the counting technique was limited, but sufficient to 
compare EEF-densities in different populations of rats. 
d) There was an indication of a linear relationship between numbers of in-
oculated sporozoites and developing EEF. It seemed unlikely that a clear 
relationship exists between doses from different batches of mosquitoes, in 
different experiments. 
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e) In comparative studies it was found that two months old rats are suscep-
tible hosts for pre-erythrocytic stages and that the infectivity of sporo-
zoites is fairly well preserved in Grace's insect TC medium at pH 7. 
f) It was confirmed that chloroquine, administered with the drinkingwater, 
has no effect on the number of developing EEF. 
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C H A P T E R IV 
THE EXPERIMENTAL WORK ON' ANTI-SPOROZOITE RESPONSES 
A.1 Studies on the immunization with sporozoites. 
The aim of these studies was to investigate whether non attenuated sporo-
zoites of P.berghei induce a response, which subsequently inhibits the in-
vasion and development within liver parenchymal cells, after a succeeding 
inoculation of sporozoites. 
Therefore a series of experiments was started with animals that were pro-
tected against following parasitaemias by chloroquine. This drug affects 
» 
exclusively the erythrocytic stages and leaves the pre-erythrocytic stages 
undisturbed (see section 3.3.4). In these experiments, animals received 
varying doses of sporozoites, and responses were recorded as altering den-
sities of EEF after a challenge with sporozoites. 
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Experiment I The effect of a single previous inoculation with sporo-
zoites on a sporozoite challenge. 
15 Two month old rats were intravenously inoculated with sporozoites 
(75.000/rat). Chloroquine was subsequently added to their drinking water. 
60 Hours afterwards 8 animals (El) received a sporozoite challenge 
(105.000/rat) that was also administered to 8 control rats (CI). After 
45 hours median liver lobes were fixed; EEF were counted and expressed 
2 
per mm of covered tissue. The 7 remaining rats (E2) were challenged 
after one week (85.000/rat), 7 control rats (C2) received the same in-
oculum, and after 45 hours as above their livers processed as described. 
The results are tabelled below (table 4.1.1). The means of groups El and 
E2 differed significantly from the means of their controls (p<0.001, 
resp. p<0.002); the mean number of EEF in group El and E2 were 17% and 
15% respectively of that of CI and C2. In 2 animals of the group E2 no 
EEF could be demonstrated at all. 
Table 4.1.1 
El 
(60 h) 
0,011 
0,015 
0,016 
0,017 
0,020 
0,025 
0,060 
0,100 
M 0,023 
sd 0,015 
1 
CI 
(control) 
0,080 
0,095 
0,102 
0,104 
0,120 
0,149 
0,187 
0,230 
0,133 
0,052 
E2 
(1 week) 
0,0 
0,0 
0,004 
0,004 
0,014 
0,040 
0,080 
C2 
(control) 
0,037 
0,099 
0,126 
0,150 
0,153 
0,161 
0,223 
0,020 
0,030 
0,136 
0,058 
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Experiment 2 The effect one and two previous inoculations. 
The experiment was extended with a group to which a second inoculum was 
adninistered before challenge. 15 Animals (El and L2) received a primary 
inoculum of sporozoites (110.000/rat) and after A days 7 of them (E2) 
got a second dose (100.000/rat). 12 Days after the first inoculation 
both groups were challenged with 150.000 sporozoites/rat and 8 control 
rats (C) received the same dose. From the results of this experiment 
(table 4.1.2) it was concluded that the first group El did differ sig­
nificantly from the control C(p=0,01). The mean number of EEF in group 
El was 69% of the control group C. The mean of the twice inoculated 
group E2 differed from that of the control group at a highly signifi­
cant level (p<0,00l) and here the mean number of EEF was only 6% of that 
of control group С Furthermore the difference between groups El and 
E2 was highly significant (p<0,001). 
Table 
M 
sd 
4.1.2 
El 
(1 dose) 
0,099 
0,100 
0,108 
0,143 
0,150 
0,156 
0,164 
0,210 
0,141 
0,038 
E2 
(2 doses) 
0,0 
0,006 
0,010 
0,012 
0,013 
0,015 
0,027 
0,012 
0,008 
С 
(control) 
0,149 
0,151 
0,187 
0,197 
0,207 
0,215 
0,218 
0,315 
0,205 
0,052 
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Experiment 3 The effect of two previous inoculations. 
The previous experiment was repeated in a slighty different way. Λ group 
of 8 rats (El) received 220.000 sporozoites per animal and after 5 days 
another group of 6 (E2) received a primary dose of 120.000 sporozoites 
per animal. Simultaneously, animals of the first group (El) received a 
second dose of 60.000 sporozoites. Both groups were challenged a week 
later (135.000/rat) and 8 control (C) rats were also inoculated with this 
dose. The results (table 4.1.3) show a quite distinct outcome, when com­
pared with the earlier experiments. In the once inoculated group E2 only 
2 animals showed EEF, and in the animals (El) that had received 2 in­
oculations no EEF were detected. 
The differences with the control group are highly significant (p<0,00lj 
Table 4.1.3 
M 
sd 
R 
(1 
E2 
dose) 
0,0 
0,0 
0,0 
0,0 
0,008 
0,009 
0,003 
(0,004) 
0,0-0,009 
El 
(2 doses) 
0,0 
0,0 
0,0 
0,0 
0,0 
0,0 
0,0 
0,0 
0,0 
с 
(control) 
0,057 
0,058 
0,063 
0,066 
0,068 
0,071 
0,073 
0,128 
0,073 
0,023 
The results of experiments 1-3 were consistent with the observed phenomenon 
of reduced densities of EEF after one or two previous inoculations with spo­
rozoites. However, the range of reduction as assessed by the counting method 
varied widely. The results from experiment 2 and 3 indicated that a second 
dose further reduced the density of EEF originating from the challenge in­
oculation. Therefore the question was how many booster inoculations would be 
necessary in order to achieve observed absence of EEF development induced by 
the challenge inoculation. For this purpose two experiments were done in 
which 1-4 boosters were administered after a primary sporozoite inoculation. 
The first dose always contained more sporozoites than the following ones. 
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Experiment A Effect of repeated doses of sporozoites on a sporozoite 
challenge. 
4 groups of 4 animals were immunized with varying doses of sporozoites. 
4 animals served as the control (group C). A first group (El) received 
an immunizing dose (150.000/rat). After one week this group was boosted 
with 50.000 sporozoites per rat and at the same time a second group (E2) 
was inoculated with the primary immunizing dose (150.000/rat). The next 
week a third group E3 received the same primary dose, whereas the others 
were boosted with 50.000 sporozoites. The fourth week experimental group 
E4 got the primary dose, and the other groups E1-E3 got their booster in­
oculations, thus creating series E1-E4 of animals treated with 4-1 sporo­
zoite doses. One week after the last dose all animals were challenged 
(100.000/rat) and the median lobes were fixed 45 hours later. 
The results are given in table 4.1.4. Only in 2 out of 4 animals of group 
E4 could some EEF be demonstrated and even in them the mean number was 
below that of the control animals; in none of the other animals EEF could 
be detected. 
E4 С 
(1 dose) (control) 
0,0 0,019 
0,0 0,045 
0,009 0,064 
0,012 0,108 
M 0,0 0,0 0,0 0,005 0,059 
sd * (0,006) 0,037 
R 0,0-0,012 
Experiment 5 Effect of repeated doses. 
The previous experiment was repeated with immunizing doses of about 
300.000 sporozoites per rat and boosters of about 60.000 per rat. 5 groups 
of three animals each E1-E5 were immunized with 5-1 doses. The challenging 
dose consisted of 200.000 sporozoites and was administered one week after 
the last dose to all animals. In none of the immunized animals could a 
single EEF be demonstrated as can be seen in table 4.1.5 
Table 4.1.4 
El 
(4 doses) 
0,0 
0,0 
0,0 
E2 
(3 doses) 
0.0 
0,0 
0,0 
0,0 
E3 
(2 doses) 
0,0 
0,0 
0,0 
0,0 
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Table 
M 
sd 
4.1.5 
El 
(5 doses) 
ο,ο 
ο,ο 
0,0 
0,0 
E2 
(4 doses) 
0,0 
0,0 
0,0 
0,0 
ЕЗ 
(3 doses) 
0,0 
0,0 
0,0 
0,0 
Е4 
(2 doses) 
0,0 
0,0 
0,0 
0,0 
E5 
(1 dose) 
0,0 
0,0 
0,0 
0,0 
С 
(control) 
0,153 
0,202 
0,250 
0,202 
0,048 
From the experiments 1-5 we got the impression that an immunizing dose, 
followed by 2 boosters prevented the development of EEF in liver parenchymal 
cells in all rats after challenge. 
Experiment 6 Effects of previous exposures to infected mosquitoes on 
intravenous challenge. 
Attempts were made to immunize animals via bites of infected mosquitoes. 
7 Rats (El and E3) were each exposed to 50 female,?, berghei infected 
anophelines, three times at intervals of one week. 
Three other rats (E2) were bitten once. Ten days later the latter group 
and 3 rats of the former group (El) were challenged i.v. (700.000/rat), 
together with animals that had been bitten previously by non-infected 
mosquitoes (CI). The four remaining animals (E3) were challenged after 
11 months (200.000/rat). Group C2 animals similarly exposed to uninfec­
ted anophelines, served as controls for the latter group. Results of 
both challenges are given in table 4.1.6. In none of the 3x exposed 
animals (El) EEF were detected, whereas the group E2 differed signifi­
cantly from group CI ( p=0,05). These results suggest that animals can 
be immunized adequately with naturally transferred sporozoites. The mean 
EEF number of group E2 was 57, of that in group CI. After about one year 
the interfering effect is still present as judged by the significant 
difference (p=0.03) between the results of groups E3 and C2; the mean 
number of EEF in group E3 was 21% of that in control group C2. 
Another group of animals was immunized via bites of 10 mosquitoes per 
rat. Through a technical failure the chloroquine had been kept away too 
early and all animals developed parasitaemias after the fourth booster-
biting. This indicates that these animals were not protected by 3 ex­
posures to 10 mosquito bites with intervals of one week. 
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Table 4.1.6 
El E2 Cl ЕЗ C2 
(3 exposure^ (1 exposure) (control) (3 exposures) (control) 
0,0 
0,0 
0 , 0 
M 0,0 
sd 
0 ,008 
0,010 
0,021 
0 , 0 1 3 
0,007 
0,128 
0,150 
0,514 
0,264 
0,217 
0 , 0 2 3 
0,026 
0 ,032 
0,034 
0,029 
0 ,005 
0,067 
0,134 
0 , 2 0 3 
0 ,135 
0 ,068 
Experiment 7 Influence of contaminants in the sporozoite doses, used 
for inmunization. 
As indicated by the results of the previous experiment, there were no 
obvious reasons to suppose that the reduction in EEF-density was a· non­
specific effect, due to repeated contact with saliva of biting mosquitoes. 
However, by the artificial way of intravenous inoculation, suspensions 
of triturated salivary glands were used. These inocula always contain some 
debris, despite centrifugation. The possible effects of responses to 
these contaminants were studied. 
5 Animals (group El) were immunized with suspensions of salivary glands. 
These suspensions had been prepared by dissecting out the glands of 25 
non-infected mosquitoes and by suspending them in a homogenizer. The sus­
pensions were gently centrifuged and from the supernatants, containing 
little particulate material, 0,5 ml was injected per animal, three times 
at weekly intervals. Two weeks after the last dose the animals were 
challenged with sporozoites (90.000/rat) prepared in the similar, normal 
way, whereas nontreated rats of the same age got the same dose (group 
CI). In table 4.1.7 A the results are listed. A significant difference 
could not be demonstrated, thus the distributions of both populations 
are considered equal. The mean of samples in group El is 80% of that in 
group CI. 
In addition a group of 8 rats (E2) was immunized with supernatants of 
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centrifugea suspensions of complete triturated thoraces. These super-
natants still contained considerable amounts of mosquito debris and micro-
organisms. On 3 subsequent weeks these suspensions were inoculated i.v. 
and one week after the last dose, the animals and those of control group 
C2 were challenged with similarly treated suspensions containing sporo-
zoites (125.000/rat). Results are given in table A.1.7 B. It was ob-
served that the means of the immunized and control groups differed 
significantly (p=0,05). The mean number of EEF in group E2 was 55% of 
that in the control group C2. 
Table 4.1.7 
Experiment 7A Experiment 7B 
El 
0,03 
0,04 
0,04 
0,06 
0,08 
M 0,050 
sd 0.020 
CI 
(control) 
0,02 
0,04 
0,05 
0,09 
0,11 
0,062 
0,037 
E2 
(thoraces) 
0,0 
0,025 
0,027 
0,052 
0,058 
0,065 
0,090 
0,110 
0,053 
0,036 
C2 
(control) 
0,054 
0,067 
0,092 
0,093 
0,107 
0,107 
0,124 
0,131 
0,097 
0,026 
Results of both parts of experiment 7 indicate that to avoid nonspecific 
interference, care should be taken to use sporozoite suspensions that are 
as purified as possible. Thus, in this study salivary glands dissected from 
infected mosquitoes were always used. 
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Experiment 8 Longitudinal effect of immunization with sporozoites. 
Next the question of the maintenance of the preventive effect was 
studied. 23 Rats received three doses of sporozoites with intervals of 
one week, (100.000, 65.000 and 35.000/rat); one week after the last dose 
5 of these animals (El) were challenged (135.000/rat) and 6 control rats 
(CI) received the same dose. This procedure was repeated every following 
week, using 6 of the immunized rats. The challenging doses were respec-
tively 215.000, 140.000 and 125.000 sporozoites per rat. The results are 
given in table 4.1.8. It became obvious that the prevention of EEF de-
velopment was not induced in the expected way (see experiment 1-5). The 
fourth week challenge caused detectable EEF in all animals, but in the 
groups challenged earlier, varying numbers of animals were found to show 
no parasites. Nevertheless, in each experimental group a significant 
(p<0,05)difference was demonstrated with the mean number of EEF in res-
pective control groups. 
The mean number of EEF in the group EI-E4 were respectively 1%, 6%, 3% 
and 7% of that of the respective control groups CI-C4. 
Table 4.1.8 
El CI E2 C2 
(ch.1 week) (con t ro l ) (ch.2 weeks) (cont ro l ) 
0 , 0 
0 , 0 
0 , 0 
0 , 0 
0 ,01 
0 , 1 2 
0 , 1 4 
0 , 2 4 
0 ,26 
0 , 4 0 
0,41 
0 , 0 
0 , 0 0 3 
0 , 0 0 3 
0 ,007 
0 ,009 
0 ,040 
0 , 0 6 3 
0 ,076 
0 ,127 
0 , 1 6 3 
0 ,168 
0 ,197 
0 ,236 
0 , 2 4 2 
M 
sd 
R 
0 , 0 0 2 
( 0 , 0 0 4 ) 
0 , 0 - 0 , 0 1 
0 , 2 6 2 
0 ,124 
0,010 0,162 
(0,015) 0,068 
0,0-0,040 
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ЕЗ СЗ Е4 С4 
(ch.3 weeks) (control) (eh.A weeks) (control) 
0,0 0,044 0,003 0,070 
0,0 0,070 0,004 0,072 
0,0 0,092 0,008 0,073 
0,0 0,104 0,011 0,108 
0,011 0,106 0,011 0,117 
0,012 0,149 0,017 0,147 
0,273 0,149 
0,201 
0,233 
0,009 0,130 
0,005 0,058 
M 
sd 
R 
0,004 
(0,006) 
0,0-0,012 
0,130 
0,075 
Experiment 9 The protective aspect of the anti-sporozoite response. 
The preventive effect of immunization with sporozoites on developing EEF 
after a challenge was further explored. 5 animals (E) received an immunizing 
dose of 200.000 sporozoites per rat and 3 subsequent booster inoculations at 
intervals of one week (60.000/rat). A week after the last dose of sporozoites 
chloroquine was removed from the drinking water. One month later these ani­
mals and the control group С were challenged with 125.000 sporozoites and 
after 45 hours a liver biopsy was performed. The immunized and control groups 
were kept alive and daily bloodsmears were made over a fortnight. One im­
munized rat showed a patent infection, two days after the mean day of patency 
of the control group; in the other 4 animals no parasitaemia was induced. 
The five control animals became patent, indicating that the time lapse between 
the end of chloroquine treatment and challenge was enough to minimalize the 
suppressive effect. The results of counting EEF in the biopsies are given in 
table 4.1.9. EEF could not be demonstrated in experimental group E, and 
apparently 4 of 5 immunized animals were fully protected against parasitaemia. 
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Table 4.1.9 
E С 
(imm.) (control) 
0,0 0,008 
0,0 0,010 
0,0 0,012 
0,0 0,020 
0,0 0,022 
M 0,0 0,014 
sd 0,006 
Experiment 10 Further extent of challenge 
The interval between challenge inoculum and immunizing dose was extended 
further to in the following experiment. 4 animals (E) received 4 booster in­
oculations (+ 75.000/rat) after an immunizing dose (160.000/rat). They were 
challenged 3 months after the last booster with 100.000 sporozoites, together 
with 5 control animals (C) of the same age. As can be seen in table 4.1.10, 
no EEF could be detected in the immunized animals (p=0,03) 
Table 4.1.10 
E С 
(imm.) (control) 
0,0 0,018 
0,0 0,047 
0,0 0,054 
0,0 0,063 
0,098 
M 0,0 0,056 
sd 0,029 
Experiment 11 Anti-sporozoite responses in rats of different ages. 
Animals of different ages were immunized, for the study of age dependency 
in anti-sporozoite inmune response of rats. 
-64-
Groups of 3 week (El), 2 (E2) and 4 month (E3) old rats, consisting of 
5 animals each, p,ot an immunizing dose of 120.000 sporozoites and 2 booster 
inoculations (44.000 and 75.000/rat) at intervals of one week. 
Groups of 3 (CI, C3) and 2 rats (C2) served as controls. All animals were 
challenged 2 weeks after the last booster with 75.000 sporozoites. Results 
are given in table 4.1.11, body-weights and liver-volumes are also given. 
It seems that the E2 and E3 group were especially well immunized. In both 
groups only one positive case was found, with a low number of EEF. 
The means were 1%, resp. 2% of that of the controls. This contrasted sharply 
with the young group, in which EEF were easily found in all animals. In this 
case the mean number of EEF was 16% of that of the control group CI. Though 
this is a considerable reduction, this small experiment gives an indication 
that in adult rats the reductions are more pronounced than in young animals 
and probably not in proportion to increase in body-weight and liver-volume. 
Table 4.1.11 
young rats young rats old rats 
body-weight (g) 101,5+5,4 157,3+ 14,6 185,9+ 8,2 
liver-volume (ml) 2,3+0,2 2,9+ 0,2 3,1+ 0,2 
El CI E2 C2 E3 C3 
0,008 0,180 0,0 0,029 0,0 0,007 
0,021 0,198 0,0 0,120 0,0 0,025 
0,034 0,249 0,0 0,0 0,139 
0,048 0,0 0,0 
0,061 0,007 0,007 
M 0,034 0,209 0,001 0,074 0,001 0,057 
sd 0,021 0,036 (0,003) 0,064 (0,003) (0,0072) 
R 0,0-0,007 0,0-0,007 0,007-0,139 
- 6 5 -
4.1.1 Conclusions 
The results of this series of experiments show that the development of EEF 
can be prevented in rodents by repeated inoculation with sporozoites of 
P. berghei. This appeared to be a gradually developing mechanism. 
One previous inoculation caused already a decrease in the density of EEF, 
but the effectiveness of a single immunizing dose of sporozoites to a chal-
lenge appeared variable. The preventive effect gathered strength with in-
creasing numbers of booster inoculations, and finally resulted in the failure 
to detect EEF. The number of inoculations to achieve this response also var-
ied, but generally 2 to 3 boosters after one immunizing dose were sufficient 
to reduce the number of detectable EEF to zero. 
The counting technique has limitations which became obvious when animals were 
kept alive after biopsy. Occasionally, a delayed parasitaemia could appear, 
even though no EEF had been detected in the biopsy. Further studies with 
standardized inocula are needed to establish a procedure which leads to a 
completely protective response. 
The preventive effect was found to be maintained in the experimental animals 
for several months, though not always at the same level. Even after a year 
considerable reduction could still be detected. 
The preventive effect could also be demonstrated after intravenous challenge 
with sporozoites, following exposures to infected mosquitoes. 
It was shown that the small quantities of mosquito contaminants, inoculated 
with sporozoites did not cause such an effect. Only when the animals were re-
peatedly inoculated with considerable amounts of mosquito tissue and subse-
quently challenged with sporozoites in heavily contaminated suspensions a 
significant decrease of EEF was established. 
It was found that adult rats of different ages can be immunized equally well. 
Young rats, however, show a much smaller reduction of EEF. 
Whether this is related to their optimal susceptibility to sporozoites remains 
unclear. 
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4.2 Studies of mutual short-term interference of pre-erythrocytic stages. 
During the pre-erythrocytic stages interference of sporozoite induced in-
fections was observed in animals that had been challenged 60 hours after 
one previous immunizing dose of sporozoites (see section 4.1, exp. 1). 
At that time virtually all EEF had already completed schizogony, and mero-
zoites had been liberated before the sporozoite challenge. Therefore the 
question arose as to whether such an interference could also be demonstrated 
in challenge infections given before complete maturation of EEF from the 
primary dose of sporozoites. 
Experiment 1 Effect of one previous sporozoite infection on the in-
fectivity of sporozoites, inoculated after 24 hours. 
Three groups of 3 rats were used in a pilot attempt. Groups CI and E 
were inoculated with sporozoites (250.000/rat) and after 24 hours 
groups E and C2 received a second inoculum (300.000/rat). Group CI 
served as a control of the first inoculum. Livers were fixed after 45 
hours. Group E was the experimental group, whereas group C2 served as 
control for the second inoculum. Livers of groups E and C2 were fixed 
45 hours after the second inoculum. 
Results are listed in table 4.2.1 and those of E and C2 were compared. 
The mean values indicate a possible difference between the groups 
(p-0.10). The mean of E was 22% of that of C2. The experiment was re-
peated with larger groups of animals. 
Table 4.2.1 
Cl E C2 
(control 1st inoc.) (twice inoc.) (control 2nd inoc.) 
M 
sd 
1,54 
1,28 
0,87 
1,230 
0,338 
0,13 
0,40 
0,29 
0,273 
0,136 
1,33 
2,07 
0,33 
1,243 
0,873 
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Experiment 2 Infectivity at re inoculation after 24 hours. 
3 Groups Cla, Clb and E, each consisting of 7 rats received a primary 
inoculation with sporozoites (150.000/rat). After 24 hours a second 
sporozoite inoculum (150.000/rat) was administered to groups U and C2. 
Group Cla was used as a control for the first inoculation. The median 
lobes of these animals were fixed after 45 hours. Animals of group Clb 
were killed after 69 hours, together with those of groups E and C2. The 
results of group Clb would give information about a possible persistance 
of EEF from the first inoculum. Animals of the twice inoculated group E 
were killed 45 hours after the second inoculation together with the 
control animals of group C2. The results are listed in table 4.2.2. No 
EEF could be demonstrated in group Clb, but numerous cell infiltrations 
indicated that merozoites had been liberated. Numbers of EEF in group E 
were thus considered to originate from the second inoculum of sporozoites. 
The mean of this group was found to be significantly differed from that 
of control group C2 (p=0,01) and the nean of E was 35% of that of C2. 
Table 4.2.2. 
Cla Clb E C2 
(control 1st (control st (twice inoc.) (control 2nd inoc.) 
inoc.45 h.) inoc. 69 h.) 
0 ,06 
0 , 0 8 
0 , 1 4 
0 , 1 6 
0 , 2 5 
0 ,27 
0 ,31 
M 0 ,181 
sd 0 ,097 
0 , 0 
0 , 0 
0 , 0 
0 , 0 
0 , 0 
0 , 0 
0 , 0 
0 , 0 
0 , 0 0 3 
0 ,01 
0 ,02 
0 ,04 
0 , 0 5 
0 , 0 5 
0 , 0 9 
0 , 0 3 8 
0 ,030 
0 , 0 3 
0 , 0 5 
0 , 0 8 
0 , 1 2 
0 , 1 3 
0 , 1 6 
0 , 1 8 
0 ,107 
0 ,056 
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Experiment 3 Infectivity at reinoculation after 20 hours. 
In addition to experiment 1 and 2 the time lapse between both inocu­
lations was shortened to 20 hours. The first dose (200.000/rat) was ad­
ministered to groups CI (4 rats) and E (6 rats), whereas groups E and 
C2 (4 rats) got a second sporozoite inoculum (85.000/rat). Results are 
expressed in table 4.2.3. Means of groups E and C2 again differed signi­
ficantly (p=0,01) and the mean of E was 352 of that of C2. 
Table 4.2.3 
Cl E C2 
(control 1st inoc.) (twice inoc.) (control 2nd inoc.) 
0,21 0,03 0,09 
0,24 0,03 0,14 
0,26 0,05 0,21 
0,31 0,06 0,27 
0,07 
0,13 
M 0,255 0,062 0,177 
sd 0,042 0,037 0,079 
Experiment 4 Infectivity at reinoculation after 16 and 8 hours. 
The interval between the first and the second inoculation was further 
shortened to 16 and to 8 hours. Groups Cla, b, с and El,2 got a 
primary inoculation of sporozoites (120.000/rat). Animals of groups El 
and C2 were reinoculated after 8 hours (200.000/rat) and those of groups 
E2 and C3 received their second dose 16 hours after the first one 
(240.000/rat). Animals of group Cla were killed after 45 hours, and gave 
positive information about the infectivity of sporozoites of the first 
inoculation. 4 Rats of group Clb were killed after 8 + 45 = 53 hours, 
together with El and C2. 
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3 Other rats (Clc) were killed after 16 + 45 = 61 hours, together with 
E2 and C3. The results of both groups Clb and Clc served as indicators 
for a possible persistence of KEF from the first inoculum.In table 4.2.4 
the results are given. The presence of EEF in Clb rats, killed after 
53 hours together with groups lì. 1 and C2, means that persistence of some 
EEF is also likely in animals of group El, but this number is considered 
negligible, conpared with the numbers of EEF due to the second inocu-
lation. The means of El and C2 appeared to differ significantly (p=0,01) 
and El was 50% of C2. 
After 61 hours the Clc rats failed to show EEF. Therefore presence of 
persistent EEF of the first inoculum in group E2 animals was considered 
unlikely. The means of E2 and C3 showed a significant difference 
(p=0,01), expressed as 41Z. 
Cla Clb Clc El C2 E2 C3 
(controls 1st inoculation) (2x inoc.) (control) (2x inoc.)(control) 
45 h 53 h 61 h 8 h 8 h 16 h 16 h 
0,13 0,004 0,0 
0,13 0,005 0,0 
0,16 0,005 0,0 
0,19 0,008 
0,152 0,005 0,0 
d 0,029 0,002 
0 , 0 6 
0 ,07 
0 , 1 0 
0 , 1 0 
0 ,15 
0,21 
0 ,29 
0 ,32 
0 ,162 
0 ,100 
0 , 2 5 
0 , 3 0 
0 ,37 
0 , 4 0 
0 ,330 
0 , 0 6 8 
0 , 0 4 + 
0 ,07 
0 ,17 
0 , 2 4 
0 , 2 4 
0 ,25 
0 ,26 
0 , 6 3 
0 ,237 
0 ,180 
0 ,39 
0 , 5 0 
0 , 5 8 
0 , 8 3 
0 ,575 
0 ,187 
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Experiment 5 Infactivity at reinoculation after 36 hours. 
Interfering influence of one previous inoculation was also studied 
over a period of 36 hours. Groups CI and E each containing 5 rats, were 
inoculated with sporozoites ( 120.000/rat) and after 36 hours groups E 
and C2 received a second inoculum (100.000/rat). Results are given in 
table 4.2.5. An indication for difference (p=0,10) could be demon-
strated between the means of group E and C2; the mean of E was 52% 
of that of C2. 
Table 4.2.5 
CI E C2 
0,048 0,020 0,022 
0,059 0,022 0,045 
0,079 0,035 0,057 
0,104 0,041 0,127 
0,105 0,046 
M 0,079 0,033 0,063 
sd 0,026 0,011 0,045 
Experiment 6 Influence of the sporozoite dose of the first inoculum on 
infectivity of reinoculated sporozoites. 
In order to study the interfering capacity of the first inoculation, 
sporozoite suspensions of different concentrations were prepared and ad-
ministered to three groups of 7 animals (El:300.000/rat; E2:30.000/rat; 
E3:3.000/rat) 2 Animals of each (CI, C2 and C3) group were killed after 
45 hours, to control infectivity. The remaining animals together with 8 
controls (C4) received second sporozoite inoculum after 20 hours (55.000/ 
rat). 
Results are given in table 4.6.6. The means of groups El, E2 and E3 all 
differed significantly from that of group C4 and the mean numbers of El, 
E2 and E3 were respectively 13, 47 and 44% of that in C4. 
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Mutually the subgroups differed as follows: 
El • 
El -
El -
- E2 
- E3 
- C4 
p-0,032 
p=0,047 
p=0,001 
E2 • 
E2 · 
E3 • 
- E3 
- C4 
- C4 
p=0,29 (n.s) 
p=0,017 
p=0,02 
(n.s.= non sißnificant) 
As indicated by the similar results of the control groups C2 and C3, some 
irregularity might have occurred with the sporozoite dilutions. The equal 
means of E2 and E3 may be due to this presumed technical failure. Neverthe-
less the comparison of El and E2, E3 with C4 indicate a dose dependent 
interference on the second sporozoite inoculum after the first injection. 
The experiment was repeated. 
Table 4.2.6 
El E2 E3 C4 
0,0 0,001 0,0 0,027 
0,0 0,001 0,003 0,029 
0,0 0,020 0,014 0,048 
0,0 0,021 0,035 0,066 
0,010 0,031 0,042 0,066 
0,020 0,056 0,047 0,069 
0,071 0,048 0,094 
0,101 
0,062 
0,029 
M 
sd 
R 
0,006 
(0,011) 
0,0-0,027 
0,024 
(0,026) 
0,001-0,071 
0,024 
0,021 
CI C2 C3 
0,126 0,010 0,008 
0,282 0,054 0,056 
- 7 2 -
Experiment 7 Dose related interference. 
The initial inocula consist of similar numbers of sporozoites and the 
second inoculum was administered after 24 hours (110.000/rat). Results 
are given as in experiment 6, in table 4.2.7. 
Mutual difference and levels of significance were as follows. 
El - E2 p=0,31 (n.s) E2 - E3 p-0,04 
El - E3 p=0,036 E2 - C4 p<0,01 
El -C4 p=0,01 E3 - C4 p=0,07 (n.s) 
The mean numbers of El, E2 and E3 were respectively 26, 33 and 58% of the 
mean in controlgroup C4. With some care it can be concluded that the 
interference with infectivity of the second inoculum is dependent on the 
number of previously inoculated sporozoites. 
Table 4.2.7 
El E2 
0,0 0,027 
0 , 0 0 ,028 
0,047 0 ,046 
0 ,060 0,071 
0 ,088 0 ,080 
0 ,129 0 , 0 8 3 
0 ,163 0,161 
0,212 
M 0,069 0 , 0 8 8 
sd 0,054 0,054 
Cl C2 
0 ,192 0 , 0 3 5 
0,247 0 ,055 
- 7 3 -
E3 С 
0 , 0 5 3 0 ,125 
0 ,095 0 , 2 9 8 
0 ,103 0 ,308 
0,112 0,311 
0,121 
0,167 
0,241 
0,320 
0,151 0 ,260 
0 ,083 0 ,083 
C3 
0,006 
0,009 
Ilxperinent 8 Influence of salivary gland tissue on infoctivit> of sporo-
¿oilos, inoculateti 4l\orLly after^Mrds. 
\ control cxperiii rnt was norforned to exclude the possibility t'iat the 
interference \;,іч due to t'iL ""osquito tibsue, inoculated vi th tl'e first 
('ose. 
Triturated salivary '-.lands of non-infected mosquitoes were inoculated 
into 8 anin.ils (¡;roup L) w'iicìi uere reinoculated after 2Д hours with 
sporozoites (")0.0ü0/rat) at the sane tine as control rats (C.2) . The 
results are p.iven in table 4.2.8. .Jo indication for a difference between 
('roups Γ and Γ2 could be found. 
Table 4.2.3 
ft 
sd 
1. 
0,007 
0,007 
0,036 
0,037 
0,050 
0,065 
0,087 
0,100 
0,049 
0,034 
С 
0,003 
0,011 
0,012 
0,013 
0,055 
0,076 
0,090 
0,110 
0,046 
0.042 
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Experinent 9 Influence of a roinoculation on number and size of CEF 
of the previous infection. 
Finally, it was investigated as to whether the development of FEF of the 
first inoculum niftht be influenced by the second. Thus, two groups of 
aniñáis Cl and E were inoculated with sporozoites (200.000/rat). Group 
E was reinoculated after 20 hours (85.000/rat) and animals of both 
groups killed 45 hours after the first inoculum. AL that time, it is 
still impossible to detect developing EEF of the second dose. No differ-
ence could be established between the mean numbers of EEF in botli groups. 
Table 4.2.9 
M 
sd 
0 ,01 
0 ,11 
0 ,26 
0 , 3 0 
0 , 3 0 
0 ,32 
0 ,217 
0 ,127 
С 
0,21 
0,24 
0,26 
0,31 
0,255 
0,042 
Width and length of 20 randomly chosen EEF were measured in 4 animals of 
both groups. It was supposed that the size of EEF within each of the 
groups was comparable, and that the distribution of cutting places of 
EEF in both groups was equal. Using the Uilcoxon test fo"· a normal approxi­
mation and correction for ties, no significant difference was found be­
tween the sizes in both groups (p=0,50). This means that a reinoculation 
of sporozoites does not interfere with number and size of the maturing 
EEF of the first inoculum. 
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4.2.1 Conalusionr, 
Λ limited study was initiated to see whether sporozoites, inoculated shortly 
after each other, would exert a mutual influence. 
Results showed a decrease in the numbers of EEF, when the second inoculation 
was fliven 24 hours after the first dose of sporozoites. 
This would mean that the first 24 hours of EEF development was influenced by 
already present EEF, induced by the primary dose, now in their last 24 hours 
of maturation and rupturinp, at the end of their maturation period. 
Further investÍRations alonp, this line confirmed the result of the pilot ex-
periment. Inoculations at different times during the 48 hours period of EEF 
maturation, following the first dose of sporozoites, resulted consistently 
in lower numbers of EEF. The reduction in the various groups, following re-
inoculation after 8-36 hours, generally was more than twofold and dependent 
on the number of sporozoites in the first inoculum. 
Λ reverse effect on the developing EEF of the first inoculum was not demon­
strated. A possible effect of non-infected salivary glands on subsequently 
inoculated sporozoites could be excluded. It is still impossible to explain 
the partially preventive effect of this non-specific inhibitor on EEF devel­
opment (see also section 4.4 on the possible effect of interferon). 
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4.3 Studies of interference by present and past parasitaemias. 
Λη attempt was nade to repeat earlier studies on the influence of para-
sitaemia upon ЕЕ development. The quantitation of KEF on four occasions 
parasitaenias were induced in 3-4 nonth old rats, by intraperitoneal in­
oculation of infected blood containing 5.10 parasitized erythrocytes. 
Peaks of less than 10% were reached about one week after inoculation, and 
there-after parasite densities decreased rapidly to levels below 0,5% with­
in another week. The courses of these parasitaemias are depicted in fig. 10. 
The infected animals received an intravenous inoculation of sporozoites 
at different stages of the parasitaemia. 
Experiment 1. Infectivity of sporozoites at the onset of parasitaemia. 
At the onset of parasitaemia (+ 8 parasitized erythrocytes/10.000), 5 
days after infection, 8 rats (group P) were inoculated with sporozoites 
(80.000/rat). Forty five hours after this challenge, median lobes were 
obtained at autopsy. At that time parasite density averaged 85 parasi­
tized erythrocytes per 10.000. 
Lobes of 6 control rats (group C) inoculated with the same dose were 
also collected. Results are given below (table 4.3.1). Not a single 
EEF was observed in the animals with a parasitaemia. This differed, at 
a highly significant level (p<0,001), with the results of controls, 
2 
which showed a mean number of 0,014 EEF/iran liver tissue. 
Table 4.3.1 
Ρ С 
(parasitaemia) (control) 
0,0 0,006 
0,0 0,008 
0,0 0,014 
0,0 0,017 
0,0 0,020 
0,0 0,020 
0,0 
0,0 M 0,014 
sd 0,006 
mean parasite density 
(infected rbc/10000 
300 exp 4 3 1 
200 
400 , 
300 
200 
exp 4 3 2 
8 10 12 8 10 12 
days 
Ъд. 20. Courses of parasitaemias in rats, superinfected with sporozoites. 
+ day of inoculation with sporozoites; t day of autopsy. 
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Experiment 2. Infectivity of sporozoites at a raised parasitnenin. 
At an increasing parasitaemia (+ 128 parasitized erythrocytes/10.000) 
7 days after infection, another group of 8 rats (P) received a sporo-
zoite inoculation (10.000/rat). Results are given in table A.3.2. Forty 
five hours later no EEF were found in 5 out of 8 animals, whereas in 
3 rats very low numbers were found. The results of the whole experimental 
2 
group averaged 0,004 EEF/nm and the control group (C) of 8 rats had a 
2 
mean of 0,052 EEF/mm . The means differed at a highly significant level 
(p<0,001). The mean numbers of EEF in group Ρ was 6% of that in group C. 
Table 4.3.2 
Ρ С 
(parasitaemia) (control) 
0,0 0,007 
0,0 0,020 
0,0 0,029 
0,0 0,046 
0,008 0,065 
0,008 0,070 
0,012 0,071 
0,108 
fl 0,004 0,052 
sd (0,005) 0,033 
R 0,0-0012 
Experiment 3.Infectivity of sporozoites at a lowering parasitaemia. 
Λ group of 8 rats (Ρ), in which the parasite density was decreasing 
after a peak parasitaemia (83 parasitized erythrocytes/10.000), was 
challenged with sporozoites (105.000/rat) on day 10 after infection. 
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Results are given in table A.3.3. Forty five hours later no EEF were 
found in 3 of these rats. The results of the whole group averaged 0,017 
2 2 
EEF/mm and that of the control group 0,064 EEF/mm . 
The difference of these means was significant (p=0,01). The mean number 
of EEF in group Ρ was 23% of that in group C. 
Table 4.3.3 
Ρ С 
(parasitaemia) (control) 
0,0 0,014 
0,0 0,026 
0,0 0,031 
0,015 0,051 
0,016 0,058 
0,028 0,088 
0,029 0,111 
0,051 0,132 
M 0,017 0,064 
sd (0,018) 0,042 
R 0,0-0,051 
Experiment 4. Infectivity of sporozoites at a decreased parasitaemia. 
After peak parasitaemias in a ßrouP of 7 rats the levels of parasite 
density had come down to below 50 parasitized erythrocytes/10.000 on day 
8. On day 10, with a mean parasite density of 6 parasitized rbc/10.000, 
the rats (P) were challenged with sporozoites (75.000/rat) simultaneously 
with 4 controls (C). At autopsy all parasite densities had been increased 
to a mean of 82 parasitized erythrocytes/10.000. Comparison of the results 
in both groups does indicate a significant difference (p=0,055); the mean 
number of EEF in group Ρ was 50% of that in group C. 
-80-
Table Α.3.4 
M 
sd 
Ρ 
(parasi taernia) 
0,009 
0,028 
0,042 
0,042 
0,068 
0,099 
0,175 
0,066 
0,056 
С 
(control) 
0,056 
0,120 
0,157 
0,197 
0,132 
0,060 
After this series of experiments on the interfering capacity of parasitaemias, 
subsequent experinents were done in animals with past parasitaemia. The sus­
ceptibility to sporozoites was studied in animals with a solid immunity to 
the erythrocytic stages of the homologous strain of P. berghei. 
Experiment 5. Infectivity of sporozoites in animals immune to bloodstages. 
Rats that survived a first infection with parasitized erythrocytes were 
boosted after 2 months. Another fortnight later, when no parasitaemia 
could be detected, 6 of these rats (P) and 5 controls (C) received a 
sporozoite inoculum (110.000/rat). A significant difference was found 
between the means of experimental and control groups (p=0,04); the 
number of EEF in group Ρ was 44% of that in the control group C. 
Table 4.3.5 Ρ С 
(immune) ( c o n t r o l ) 
0,0 0,084 
0,027 0,174 
0,103 0,178 
0,108 0,270 
0,109 0,284 
0,176 
M 0,087 0,198 
sd 0,064 0,081 
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Experiment 6. Infectivity of sporozoites during a chronic low parasitaemia. 
10 animals that previously had survived a blood-induced parasitaemia, were 
boosted with erythrocytic stages after 2 months. They developed a chronic 
infection with parasite densities of less than 20 parasitized erythrocytes/ 
10.000. These animals (P) were inoculated with sporozoites (45.000/rat)., 
together with their infected controls (C). Results are given in table 4.3.6. 
The difference of means of groups Ρ and С appeared to be significant (p=0,01) 
and the number of EEF in group Ρ was 36% of that in the control group C. 
This confirmed thus the indications found in the previous experiment. 
Table 4.3.6 
Ρ С 
(immune) ( c o n t r o l ) 
0,0 0,005 
0,005 0,013 
0,005 0,014 
0,006 0,014 
0,009 0,020 
0,010 0,032 
0,015 0,035 
0,016 0,039 
0,020 0,047 
0,026 0,054 
0,064 
M 0,011 0,031 
sd 0,008 0,019 
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Experiment 7. Immunization with sporozoites under protection of differently 
induced liver-blood barriers. 
Λη attempt was made to inmunize rats with sporozoites whereby in part of 
the animals a liver-blood barrier was induced by stimulation of the 
immune mechanism against stages that infect the erythrocytes. No chloro-
quine was given with the drinking water. 8 Rats (P) were immunized against 
the erythrocytic stages by a blood induced infection, followed one month 
later by similar a booster. Another 5 weeks later no erythrocytic stages 
could be detected and a first sporozoite inoculum was administered 
(120.000/rat). After a week a sporozoite booster inoculation was given 
(75.000/rat). 8 Normal rats (E) were protected with chloroquine against 
erythrocyte infection and were immunized with sporozoites at the same 
tine as group P. Together with 8 control rats (C), the 2 groups of 
immunized animals were challenged one week later with 145.000 sporozoites. 
Results of this experiment are given in table 4.3.7. The means of both 
groups immunized with sporozoites (Γ and E) differ highly significantly 
from that of the control C. (p<0,001). In 7 out of 8 blood immune animals 
(P) no EEF were found, compared with 5 out of 8 chloroquine protected 
animals (E). The mean number of EEF in Ρ and E was 1%, resp. 4% of that 
in C. 
Table 4.3.7 
Ρ 
(bl< 
M 
sd 
R 
Dod 
0 
o, 
0, 
o, 
0; 
o, 
o, 
0, 
0, 
(0, 
0, 
imm. ) 
.0 
o 
,0 
,0 
.0 
0 
.0 
,007 
,001 
,002) 
,0-0,007 
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(Chlor.) 
0,0 
0,0 
0,0 
ο,ο 
0,0 
0,007 
0,008 
0,019 
0,0045 
(0,007) 
(control) 
0,057 
0,059 
0,077 
0,094 
0,110 
0,128 
0,151 
0,195 
0,109 
0,048 
4.3.1 Conclusions 
These results indicate that parasitaenia in some way interferes with the 
development of EEF in liver parenchymal cells. In all experiments, densities 
of EEF in rats with a present or past parasitaemia were lower than in controls, 
always at a sipnificant level. 
Primary parasitaemias especially caused considerable reductions of developing 
EEF during the risinp, and decreasinp phases. No EEF could be detected at all 
in 17 out of 25 rats (68%) used in the three first experiments. 
It is not clear, however, if the observed effect is correlated with parasite 
densities, or with other changes provoked by parasitaemia. 
Indications were found that animals, immune to erythrocytic stages, offer also 
a less favourable environment for infective sporozoites. 
But this immunity is obviously not able to prevent exo-erythrocytic develop­
ment completely. To achieve this effect, it is necessary to immunize with 
sporozoites.(For a possible role of interferon, see section A.4). 
4.4 Preliminar observations on some mechanisms of resistance 
4.4.1 Seroloaical findinas 
'-
20 rats were immunized under different protective regimens. 6 rats (Group N) 
were treated as normal with chloroquine, another 6 (Group M) were fed with 
PABA-deficient milkpowder and the remaining 8 (Group B) were left untreated 
during immunization. An immunizing dose of 150.000 sporozoites were adminis­
tered per animal and 3 subsequent booster inoculations at weekly intervals 
(65.000, 20.000 and 160.000/rat). 
5 rats of group В succumbed to their parasitaemias within two weeks, where­
as in the 3 remaining animals and those of the other groups no erythrocytic 
stages were found in blood smears three weeks after the immunizing dose. 
Antirsporozoite antibodies were determined in sera of these animals, obtained 
6 days and 7 weeks after the last booster. CSP reactivity was determined by 
counting 20 sporozoites and indicating the number showing precipitates; 
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Results of these determinations are listed in table 4.4.1. About three 
quarter of the sporozoites that were incubated in the sera, obtained shortly 
after immunization showed precipitates. There was a tendency that the number 
of sporozoites with precipitates slichtly decreased over the period of 6 
weeks, but this should be affirmed in titration experiments. All of the 
pooled sera (/) from imnunized rats showed SNA, in contrast with the pre-
immunization sera. 
The results indicate that treatment with chloroquine, induces similar CSP 
and SNA antibody levels as are detected in untreated animals. 
Table 4.4.1 
Group 
1 
2 
N 3 
4 
5 
6 
mean+sd 
7 
8 
M 9 
10 
11 
12 
mean+sd 
14 
В 16 
20 
mean+sd 
1 week before 
first dose 
CSP 
0+ 
0+ 
0+ 
0+ 
0+ 
0+ 
0 
0+ 
0+ 
0+ 
0+ 
0+ 
0+ 
0 
0+ 
0+ 
0+ 
0 
SNA 
/ 
/ 
/ Neg 
/ 
• 
5 days al 
last boo; 
CSP 
8+ 
19+ 
18+ 
14+ 
18+ 
18+ 
15,7+4 
16+ 
16+ 
16+ 
17+ 
18+ 
16+ 
16,5+0 
16+ 
17+ 
6+ 
13,0+6 
Eter 
ster 
Д 
,8 
Д 
SNA 
/ 
/ 
/ 
/ 
/ 
• 
/ 
/ 
Pos 
Pos 
7 weeks after 
last booster 
CSP 
15+ 
13+ 
11+ 
12+ 
15+ 
6+ 
12,0+3, 
14+ 
16+ 
7+ 
12+ 
17+ 
12+ 
13,0+3, 
5+ 
13+ 
14+ 
10,7+4, 
,3 
,6 
,9 
SNA 
/ 
• 
/ Pos 
/ 
/ 
/ 
/ Pos 
/ 
/ indicates the serum samples, pooled for detection of SNA 
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4.4.2 /1 pilot studu on the yroduation of Înierforon 
There are indications that malaria parasites induce the production of inter-
feron and other data pointing to a deleterions effect of interferon to malar-
ia parasites (both the pre-erythrocytic and erythrocytic stages). The pre-
sence of circulatinp interferon would pive an explanation for the short-term 
interference of sporozoite infectivity by a previous sporozoite inoculation 
(see section 4.2) and partially for the observed interference by parasitaemias 
(see section 4.3). 
о 
Three groups of two month old rats were inoculated with 10 erythrocytic 
stages, with 200.000 snorozoites per animal and with the artificial inter­
feron inducer r I:r С respectively. Sera were obtained at regular intervals. 
The number of plaque-forming units (PFU) was determined on a monolayer of rat 
embryonic cells, incubated with these sera and overlayed with VSV virus. 
The results of the sera from rats treated with r I:r С were consistent. With­
in 4 hours after inoculation 802 reduction of PFU was observed, while after 
about 30 hours the numbers of PFU approached again the control values. 
In the sera of rats inoculated with erythrocytic stages PFU counts fluctuated 
but never showed a 50% inhibition as compared with control plaque counts. The 
parasitaemias, which were lethal, apparently caused no induction of circu­
lating interferon at detectable levels. The sera of animals, inoculated with 
sporozoites showed no uniform pattern. In the series of two rats fluctuatinf» 
results were obtained, without a sign of difference after appearance of par­
asitaemias. In one of the series we observed a 40% reduction of PFU after 48 
hours, which might correlate with the rupture of liver parenchymal cells 
containing mature EEF. Some of the results are depicted in figure 11. It 
should be admitted that our experience is still insufficient and the perfor­
mance of the test needs improvement. However, since the results of the arti­
ficial inducer were consistent, we report here, on these preliminary results. 
4.4.3 Irmunization of normal and athyrtio nice 
In order to obtain insight into the role of the thymus in anti-sporozoite 
responses inbred BIO.LP mice, which had acquired the thymus deficiency factor 
(nude) by repeated backcrossing were immunized. Groups of athymic (nu/nu) and 
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PFU 
140η 
1 2 0 -
100 
8 0 -
6 0 -
40 
20H 
î 
о 
inoculation 
Φ · infection with erythrocytic stages 
о о infection with sporozoites 
Δ Δ artificial interferon inducer rhrC 
Ρ end of prepatent period 
1 
-V/ г 
4 6 
I г 
8 
V/ 
ι 
CO 
10 16 
days 
fig. 11. Longitudinal observation of interferon levels in three groups of rats, infected with erythrocytic 
stages, with sporozoites, or treated with an artificial interferon inducer. 
normal (nu/+) littermates received A doses of sporozoites, at weekly inter-
vals (100.000, 130.000, 30.000, 40.000/mouse). After challenge (30.000/mouse) 
3 weeks after the last booster daily blood smears were nade to monitor par-
asitaemias. It was found that the immunized nu/nu animals invariably developed 
parasitaemia within a week, as did the non-immunized nu/nu and nu/+ controls. 
Only in the imnunized nu/+ group no parasitaemia was found until 16 days 
after challenge. These results could be reproduced in a second attempt, in 
which 120.000, 20.000, 15.000 and 32.000 sporozoites/mouse were administered 
at weekly intervals. 
Two weeks after the last booster a challenge of 80.000 sporozoites/mouse 
was given. The results are expressed in table A.4.3. In the serum of the im-
munized nu/+ mice from the second attempt CSP reactivity could be demonstrated. 
8 animals of this group were rechallenged with sporozoites after an only one 
animal developed a parasitaemia. Additionally, it was observed that sporo-
zoite-induced parasitaemias in nu/+ and nu/nu mice developed similarly, but 
most nu/nu mice survived longer and some even recovered. 
Table 4.4.3 
Exp 
No. 
I 
Experimental 
Groups 
_ . . nu/nu 
Immunized 
nu/+ 
, nu/nu 
Control 
nu/+ 
Protection 
No.Animals 
Protected 
0/4 
8/8 
0/1 
0/10 
Mean Day 
Patency 
6,5 
-
5,0 
A,5 
II 
Immunized nu/nu 
nu/+ 
0/9 
12/12 
4,5 
Control nu/nu 
nu/ + 
0/7 
0/6 
4,1 
3,9 
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4.4.A Transfer of imune spleen cells 
One animal of a proup of 8 two month old inbred Wistar rats was exposed to 
infected mosquitoes 3 times a week, during a month. Another animal was simul-
taneously exposed to non-infected mosquitoes. Both received chloroquine in 
their drinking water. After the immunization procedure the spleen cells of 
each of these animals were suspended and transferred intravenously to 2 groups 
of 3 rats (group S receiving cells of the sporozoite immunized rat and group 
M those of the non-immunized rat; 1,5.10 cells per animal). 
5 hours later both groups received an intravenous sporozoite challenge 
(260.000/rat), and the median lobes were fixed 45 hours after inoculation. 
Results are given in table 4.4.4. In group S considerably less EEF were found, 
and the mean number was 29% of that in group M. 
Table 4.4. 
M 
sd 
.4 
( 
S 
imm. cells) 
0,073 
0,084 
0,111 
0,089 
0,017 
H 
(control 
0,144 
0,335 
0,456 
0,312 
0,157 
cell: s) 
4.4.5 Conclusions 
A few preliminar conclusions can be drawn from this section on mechanisms of 
resistance. 
a) Viable sporozoites induce considerable amounts of specific antibodies. 
Their production is neither influenced by chloroquine treatment, nor by 
parasitaemias. There is a tendency that CSP reactivity slightly decreases 
during 6 weeks. Neutralization activity probably indicative for the pro-
tective response, is demonstrable in all of the pooled sera except for the 
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pre-infectious sera. 
b)Clear levels of interferon are neither detectable in sera from rats with 
sporozoite-induced infections, nor in sera from rats with blood-borne in­
fections, thus contrasting with the consistent reduction of the number of 
PFU after inoculation with the artificial interferon inducer r I : r C. 
c)Mice immunized with viable sporozoites develop a protective immunity, as 
judged by the absence of parasitaemias after challenge. But all congenitally 
athymic mice, simultaneously immunized, show parasitaemias after sporozoite 
challenge. This indicates that the thymus or T-cells are indispensable for 
the upbuilding of a protective response. 
d)Spleen cells from two donors, repeatedly exposed to infected and non-infected 
mosquitoes, were transferred to inbred recipients, which were subsequently 
challenged with sporozoites. The recipients of sporozoite-immune cells showed 
considerably lower EEF-density than those of non-iirmune cells. Since no se­
paration of the leucocytes was performed it remains unclear which population 
actually caused the reduction. T-cells may be involved, as well as В cells 
and macrophages. The experiment was described to show the usefulness of the 
counting technique as a possible in VÌVO measure for immunological studies 
of the anti-sporozoite response. 
-90-
C H A P T E R V 
DISCUSSION 
5.1 Quantitative assessment of EEF-numbers in liver tissue 
Gamham and Bray (1) were the first to quantitate numbers of EEF in liver 
biopsies for the estimation of the relative density. They counted the numbers 
2 
of EEF found in a fixed area (50 mm ) of biopsy sections. The final result 
2 
was expressed as the number of EEF per mm . In another approach they counted 
the number in 20-50 sections of known area and thickness, and measured the 
3 
average diameter of the EEF. From these data the number of EEF/cm was com-
puted. The differences found between these two methods were negligible. 
Their study was performed with a few monkeys, and they noticed that it was 
necessary to carry out experiments on a larger scale, and that despite this 
quantitative approach, the results could only be used as a crude measure. In 
these and subsequent studies (2) it was tacitly assumed that the relative 
EEF density in a given biopsy is representative for the whole liver. The 
place of biopsy was not defined, however. In our present studies with rats, 
we have always taken a counting sample from a defined region of the liver, 
since we could not consistently demonstrate a uniform distribution of EEF. 
Thus, one may only assume that the density in a defined region is correlated 
in some way with the density in the whole liver. 
Also Yoeli et dl. (3) found that the distribution seems to be irregular. They 
found less EEF adjacent to the liver capsule and at the periphery of the lob-
ules. The majority of parasites was situated at the center or sides of the 
lobules, in cells near the vessels. However, they did not quantitate their 
results. 
Wéry did use a quantitative approach in his studies on rodent plasmodia. As 
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a general routine, he determined the number of EEF in 50 or 100 serial sec-
tions and assumed that the average number of EEF per section gives an indi-
cation of the intensity of infection in a piece of liver. Initially a fixed 
2 
area of 60 mm was searched per section (4), but later on this method was 
usually omitted and exclusively used to compute the number of EEF in a whole 
liver or per unit volume (5). 
We have several comments to make concerning Wéry's approach. 
The surface are of tissue sections is a variable unit: 
a) Sections, arbitrarily taken fron different lobes of a given liver and 
those from corresponding lobes in the livers of other animals differ in size. 
b) The outlines of sections are sometimes irregular and bloodvessels and 
artefacts may influence the actual tissue surface. 
c) The shape of a liver lobe may cause a gradual change of the surface of 
serial sections. 
To our opinion, the mere comparison of mean numbers of EEF per section is a 
very inaccurate approximation and we emphasize that the surface of the sec-
tions is an essential component for comparing relative EEF densities. 
The use of serial sections implies the occurrence of identical EEF in several 
sections. 
We have selected our sections, to avoid double counting. A hundred counted 
serial sections may give a more precise result than the 9 selected sections, 
used in our studies; but a search of large numbers of serial sections may not 
be necessary to get "an indication of the intensity of infection", in view 
of the accuracy with which Wéry contented himself. The optimal number of sec-
tions depends on this intensity and cannot be given beforehand, but we found 
2 
that the mean number of EEF/mm from 9 sections di4 not devi'ate from that in 
100 serial sections. We therefore preferred the less laborious approach. 
From more or less equal numbers of EEF per unit volume in two lobes of a few 
rats, Wéry concluded a uniform distribution of EEF in the liver. We could 
not consistently prove such a distribution; this matter deserves further 
attention, before extrapolation from small samples to whole lobes or livers 
is acceptable. 
Apart from these remarks, it must be admitted that Wéry's study has not been 
equalled, and that he has gathered a mass of information on sporozoite-host 
interrelationships in rodent malaria. 
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Generally, investipators appear to shrink from an histolofiical approach for 
quantitatinp, sporozoite infectivity, and the indirect, but less laborious 
approach of determining the prepatent period is chosen. Among others Fink 
has done so; he justified this choice by pointing to the precondition of 
statistical analysis of the results and the unfitness of his P. уоеігг-
mouse system for such an approach (6). 
Only occasionally has the histological method been used. Vanderberg (7, 8) 
repeatedly used the second method of Wéry, and Bafort (9) once determined 
the average number of EKF in 3 sections at a distance of 100 um in a few rats. 
A qualitative approach has been used in some studies on the influence of drugs 
(10, 11, 12). In the opinion of Most (personal communication) there is no need 
to count EEF in studies on causal prophylactic activity, provided the controls 
have an abundant number of readily detectable parasites. This is, however, an 
unreliable factor, since inocula may contain variable numbers of infective 
sporozoites. Counting techniques have their limitations, especially if the 
only interest is the presence or absence of EEF. But it may be of use when a 
partial effect of drugs on EEF is studied in animals that are susceptible to 
this stage of the parasite. In relatively unsusceptible hosts the all or none 
effect as measured by the onset of a parasitaemia remains the only suitable 
method, whereby an attempt to quantitate the effect of EEF can be made by 
determining the length of the prepatent period. 
5.2 Application of the counting method 
5.2.1. Dose of sporozoites 
An impression of the infectivity of sporozoites in a vertebrate host can be 
obtained by two methods: 
a. quantitative assessment of developing EEF 
b. duration of the prepatent period 
For use of the second method a relationship between the number of inoculated 
sporozoites and EEF has to be assumed. If that is so, then the time lapse be-
tween inoculation and appearance of parasites in the blood serves as a measure 
for the degree of infectivity in a batch of sporozoites. It is a relatively 
easy technique, which gives satisfactory results. This is the method of choice 
in those hosts which have a high innate resistance to sporozoite infection. 
Nussenzweig (13) and Vanderberg (7) and their coworkers found that, when the 
dose of sporozoite of P. berghei was increased, the prepatent period of 
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inoculated mice became shorter. This was confirmed by Gregory and Peters (14) 
who demonstrated a linear relationship between log inoculum of sporozoites 
and the mean time required to develop a 2Z parasitaemia. However, doses which 
failed to produce a 100% group patency required a similar time for develop­
ment of two percent parasitaemias, thereby demonstrating a breakdown in the 
linear relationship. Fink also found a similar linear relationship with P. 
уоеЪгг sporozoites in mice, using 0,2% parasitaemia as a measure for the pre-
patent period (15). Difficulties with regard to the reproducibility of pre-
patent periods and individual variation were, however, regularly observed. 
He therefore proposed determining the mean infective dose of sporozoite sus­
pensions (6). All these approaches presuppose a direct relation between spo­
rozoite doses and numbers of EEF. 
Our attempts to demonstrate a correlation between inoculated sporozoites and 
numbers of EEF substantiated the presupposition of others. The correlation 
between higher doses is not necessarily valid for the lower doses. Mathema­
tically a negative dose is suggested for the groups in which some of the 
animals were found to be negative. The impossibility of this substantiates 
the results of Gregory and Peters (14), who demonstrated that the linear 
relationship between sporozoite-dose and prepatent period breaks down when 
the inoculum is insufficient to give a 100 per cent group patency. Obviously 
our failure to detect EEF in animals which received the low doses, does not 
imply a total absence of this stage in the liver. 
The correlation coefficients of the data per experiment were unequal, in­
dicating that there was a difference in the number of infective sporozoites 
present in different batches of mosquitoes. This appeared to be very clear 
when our data from several experiments were combined, in order to find a 
> 
correlation between dose of sporozoites from different batches and the number 
of developing EEF. It then appeared that there was no linear relationship 
between numbers of sporozoites and EEF. This means that under these experi­
mental conditions it is not permissible to extrapolate from different sporo-
zoite-batches to numbers of EEF. Though Vanderberg et al. (7) using the 
counting technique of Wiry, reported considerable variation in "viability" 
between different pools of sporozoites and in susceptibility of individual 
rats and mice, they nevertheless concluded that by increasing the number of 
injected sporozoites, the number of observed EEF could be increased. It is 
our opinion, however, that the amount of increase is completely unpredictable. 
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5.2.2 In vitro preservation of infectivity 
We confirmed the findings of others that sporozoites of P. berghei very rapid-
ly lose their infectivity in vitro. A measure for this has generally been the 
length of the prepatent period or time lapse whereafter a certain parasite 
density is recorded. Another, more direct, measure is the number of EEF, as 
was suggested above. We demonstrated that in vitro incubation of sporozoites 
for one to two hours on ice halves the density of EEF (see section 3.3.2). 
This reduction can be minimalized when media, which preserve the sporozoites 
better, are chosen. Grace's insect TC medium suited our purpose best. Fink 
and Schicha (17) suggested its use and they found it at least as good as TC 
medium 199. The pH of the medium may vary from 5 - 7,6 without ill effect 
(Fink, personal communication). However, at present he uses pure calve serum 
instead. 
We found that sporozoites, kept for two hours in Grace's medium at pll 7 and 
additional calve serum gives rise to significantly more mature EEF than when 
kept at pH 6. The recent publication by Vanderberg (18) of the preservative 
effect of bovine serum albumin (BSA) on infectivity and motility of sporo-
zoites adds significant progress to the in vitro maintenance of this vulner-
able stage. However, BSA and serum cannot be used in experiments wherein ani-
mals are immunized by repeated inoculations of sporozoite suspensions. We 
found that adjustment of pH to 7 already suited our purpose reasonably well. 
When care is taken to keep the sporozoites in suspensions for a short time, 
the loss of infectivity is minimal and under those circumstances other media 
like TC 199 can be used with satisfactory results. 
5.2.3 Species and age of vertebrate host 
Yoeli et al.(19) found indications of differences in susceptibility of rodents 
to sporozoites of P. berghei. They found 2-4 weeks old rats more susceptible 
than tree rats, whereas mice were by far the least susceptible. 
These results were quantitated on the basis of prepatent periods and parasit-
aemias by Nussenzweig et al. (13), who confirmed a relatively high innate 
resistance of mice to sporozoites. Vanderberg et al. (7) in their attempts 
to quantitate EEF, reported that tree rats were more susceptible than young 
white rats, which in turn were more susceptible than mice (A/J). Nussenzweig 
et at. (13) also demonstrated a clear influence of age in the susceptibility of 
rats, 2-3 week old rats were far more susceptible than 2 month old rats. 
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Apparently, the innate resistance rises with age. Wiry (5) found that the 
susceptibility of mice to sporozoites of P. berphei is very disappointing. 
In 3 infected mice he examined 50 liver sections and he found only once an 
EEF. He found young albino rats 25-50 tines more susceptible than mice. With 
our counting method of EEF we could confirm most of the observations cited 
above. It was very difficult to obtain sizable numbers of EEF in the livers 
of mice. Older rats were less susceptible than young rats, whereas Tharmomys 
sp. appeared to have a susceptibility comparable to that of young Wistar 
rats. Our studies on sporozoite immunization were carried out in two month 
old Wistar rats. 
5.2.4 Effect of cloroquine on sporozoites and EEF 
Several authors have studied the causal prophylactic activity of chloroquine 
in rodent Plasmodia. Most et al. (10, 11), Gregory and Peters (14) and Fink 
(6, 16) found no indication for such an effect. It is not effective against 
pre-erythrocytic stages, but it exhibits potential suppressive activity on 
the erythrocytic stages. In other studies chloroquine was used to avoid side 
effects of parasitaemias (21); and it was recently used in attempts to im-
munize with P. fallax, to inhibit the development of erythrocytic stages, 
making it possible to judge the effect of immunization with merozoites (22). 
This encouraged us to administer this drug during our immunization procedure 
using sporozoites. We confirmed the lack of causal prophylactic activity in 
our studies, since no significant difference of EEF density in the liver could 
be demonstrated between chloroquine treated and control animals (see section 
3.3.4). Erythrocytic stages, on the other hand, are effectively suppressed. 
Nevertheless, it may be possible that chloroquine influences the immune res-
ponse. Holtz et al. (23) reported that it can interfere with antigen-antibody 
reactions. It was found in this study that, after immunization with sporo-
zoites, chloroquine treated animals showed comparable antisporozoite anti-
body activity, as milk-fed or nontreated animals (see section 4.4.1). Houba 
and Adam (24) found no effect of chloroquine on primary and secondary anti-
body response to streptococcal antigens in rabbits. 
On the other hand Panayi et al. (25) have shown that longterm chloroquine 
therapy can suppress the nonspecific stimulation of lymphocytes. In our ex-
periments control groups always received the same chloroquine regimen, and 
the observed effects of immunization were always compared with these controls. 
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In conclusion of this part of the discussion, we wish to emphasize our pref-
erence for the use of quantitating relative EEF densities as a measure for 
sporozoite-infectivity. In our hands the described nethod proved to be a 
reliable and relatively easy technique, applicable in a variety of studies 
on the pre-erythrocytic stages of malaria. 
5.3 Immunization with sporozoites 
Our results indicate that previous inoculations with sporozoites control a 
challenge infection with sporozoites considerably, as assessed by the quanti-
tation of EEF in liver parenchymal cells after the challenge. 
Possible anti-sporozoite effects of parasitaemias are excluded both in the 
approach of Nussenzweig (irradiated sporozoites) and in our method (chloroquine 
treatment). But the following differences are obvious. In our method healthy 
EEf come forward from the non-attenuated infective sporozoites. These stages 
mature unimpeded inside liver parenchymal cells and, while rupturing, they lib-
erate their merozoites. This is followed by an immediate cellular reaction of 
the host. This reaction has not been observed during the immunization with ir-
radiated sporozoites. 
We demonstrated (section 4,1, exp.l) that rats challenged 60 hours and 7 days 
after one previous inoculation showed about 86% reduction of EEF in both cases. 
Whether this affect was due to mobilized phagocytes in the liver granulomas, 
or to another type of response remains as yet unknown. 
Rivera-Ortiz and Nussenzweig (26) have drawn attention to another phenomenon 
in which phagocytosis is involved. They demonstrated an increased clearance 
of colloid carbon in mice after the inoculation of an irradiated sporozoite 
suspension. An increase after one day, an optimum after two days and a gradual 
decrease during the following 9 days was found. The possibility of a phagocytic 
mechanism being involved in the reduction of EEF from a second inoculum, that 
we have obtained camiot be excluded. The mononuclear phagocyte system might 
have been activated both by the earlier inoculation of sporozoites, and by the 
subsequent rupture of mature EEF. 
Generally, no detectable EEF were observed in rodents that received one inocula-
tion of irradiated sporozoites. The authors presumed that the penetration mech-
anism of the sporozoites remained intact after irradiation, since rare, degen-
erating EEF could be demonstrated. 
Invasion of these attenuated sporozoites thus led to the induction of an abor-
tive infection of the host cells (27, 30). It is not unrealistic to presume 
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that many of the irradiated sporozoites are phagocytosed by macrophages. The 
number of these sporozoites has never been assessed. On the other hand inocula 
of non-irradiated sporozoites will also contain numbers of non-infective, and 
even non-viable sporozoites (5,7). Garnham especially pointed out the degen-
erate forms in populations of P. berghei. sporozoites (31). It is unknown what 
role phagocytosed sporozoites play in the upbuilding of an anti-sporozoite 
immune response, and whether irradiated and non-irradiated sporozoites have 
different immunogenic capacities. 
Serological differences after inoculation with irradiated versus viable spo-
rozoites have incidentally been sought for. In a single attempt, Nussenzweig 
and Spitalny (28, 32) demonstrated persistent titres of CSP antibodies in 
rats that had received one inoculation of irradiated sporozoites. In rats in-
oculated with non-irradiated sporozoites CSP titres were also found, but after 
a short optimum the titres again decreased to normal levels. In both cases the 
antibody responses could be boosted and titres then remained high for weeks. 
From this single experiment, in which the numbers of rats was not mentioned, 
the far reaching conclusion was drawn that, though viable sporozoites are im-
munogenic, irradiated sporozoites have greater immunogenic capacity. This 
conclusion has been repeatedly quoted by others in an incomplete and inac-
curate way. 
However, they did not give data concerning the development of parasitaemias, 
and its consequences for the detectability of CSP antibodies. An experiment 
was performed in collaboration with Spitalny, to study the influence of a 
concomitant parasitaemia on the formation of CSP antibodies (see section 4.4.1). 
We found that the CSP-activity was comparable to that of chloroquine pro-
tected animals inoculated with viable sporozoites and therefore, apparently 
a parasitaemia does not interfere with the induction of an anti-sporozoite 
antibody response. Nevertheless, the conclusion of lower immunogenicity of 
viable sporozoites needs further exploration. 
We noticed that the degree of reduction of EEF numbers after a single pre-
vious inoculation varied considerably from experiment to experiment. These 
results, thus, confirm those of Nussenzweig, who found variable numbers of 
mice protected against subsequent parasitaemias (33). It is therefore not 
surprising that Yoeli could not find a reduction in EEF after one previous 
sporozoite induced infection of P. berghei in rats (3, 34). Similar negative 
results were obtained by Garnham (1, 2) using one to three previous sporo-
-98-
sporozoite induced infections of P. cynomolgi bastianellii in rhesus monkeys. 
In our experiments, the administration of a second or third sporozoite inoculum 
boosted the initial effect; the numbers of EEF after sporozoite challenge were 
further reduced, and frequently no EEF could be detected at all with the coun-
ting technique. Further increase in the number of booster inoculations almost 
invariably induced a response which prevented the development of EEF. Strict-
ly speaking, we should not use the term prevention, since only a small coun-
ting sample was taken from the median lobe. However, the single experiment in 
which parasitaemias were allowed to develop indicated that 4 out of 5 rats im-
munized with 4 doses were completely protected against induction of a parasit-
aemia resulting from a sporozoite challenge. 
Similarly complete protection was found in intact mice. The effects last for 
several months, and a certain, not protective response remains detectable for 
at least one year. These results confirm those on protection in mice that have 
been accumulated by Nussenzweig's group (35). Our immunizations, obtained with 
viable sporozoites and chloroquine treatment, have recently been confirmed in 
mice by Strickland and Beaudoin (personal coimunication). 
Increase in age of the challenged rats might bias the results. Therefore we 
always used animals of the same age in experimental and control groups. The 
increasing significance of innate resistance in rats to sporozoites has 
repeatedly been described. We got preliminary evidence for such an effect 
(see section 3.3.3). In an unreported attempt, meant to repeat the experiments 
of Nussenzweig and coworkers (36) on the time of sporozoite clearance in normal 
and immune mice, we inoculated a 1 month old and a 4 month old rat with doses 
of sporozoites, adjusted to their bodyweight. At several times after the in-
oculation, blood from these animals was subinoculated into other 1 month old 
rats, and the onset of parasitaemia assessed. To our opinion highly susceptible 
recipients are preferable to less susceptible animals like (A/J) mice. Those 
rats that received blood from the young one developed parasitaemias, even when 
the blood was transferred 1 hour after inoculation. Further delay of blood-
transfers did not result in parasitaemias. This agrees with Nussenzweig's re-
sults in mice. However, none of the animals receiving blood from the old rat 
became patent, not even when transfer was done 10 minutes after the inocula-
tion. This effect could be due to the activity of the mononuclear phagocyte 
system in older animals. The increasing importance of this form of innate 
resistance should be kept in mind as immunized rats grow older. However, the 
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results of challenge of inmunized 2 and 4 month old rats (see section 4.1, 
exp. 11) were comparable: both groups showed almost complete reduction of 
detectable ECF after two previous sporozoite inoculations. This means that 
the degree of innate resistance is already established in 2 month old rats. 
Apparently the specific anti-sporozoite response is more important than the 
innate resistance. Our results indicate that young rats behave quite distinct-
ly from o'der animals in that reduction, though impressive could not match that 
of the older groups. This may be due to a incompletely developed immune sys-
tem in young rats. 
Another possibility was also considered: in these highly susceptible young 
animals, a greater number of viable sporozoites are infective than older rats. 
These sporozoites night then be eliminated from the inmunity-inducing process 
after invading parenchymal cells of the liver. 
This consideration brings us back to the question of what actually induces 
the anti-sporozoite immune response. Is it the sporozoite itself, do infective 
sporozoites actually participate in these processes, or are only the phagocy-
tosed sporozoites immunogenic? At present this question cannot be answered, 
yet it may have practical consequences, since the relative numbers of both 
categories of sporozoites might have an impact on mounting the specific res-
ponse. 
Garnhan thought that too few sporozoites are phagocytosed to provide a suf-
ficient quantity of antigen to stimulate the production of antibodies. Never-
theless, he considered non-viable sporozoites capable of provoking an aggluti-
nation or lysin response. 
In our studies, unlike those of Nussenzweig, we have not attempted to use 
uniform immunizing doses and challenges. Only approximately similar numbers 
of infected mosquitoes were dissected and the counting of sporozoites was 
generally performed after inoculation. 
This was done for three reasons: 
a) to keep sporozoites in vitro for a short a time as possible, ensured mini-
mal loss of infectivity (37) 
b) varying infectivity in doses of sporozoites obtained at different times, 
from different batches of mosquitoes (see section 3.3.1) 
c) reliability of results depends on the use of sufficient numbers of animals 
of the same age in the experimental and control groups. It was impossible to 
guarantee that for each inoculation the required number of sporozoites would 
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be available for all animals in a f»iven experiment. 
However, our controls miRht be considered inadequate, since they only give 
information on the infectivity of sporozoites and do not reflect the reactions 
to non-infective sporozoites in experimental animals exactly. In the light of 
a probable dose dependency of the anti-sporozoite response and the mentioned 
possibility that non-infective sporozoites night be the main inducers at this 
response, we now endorse the use of predetermined numbers of sporozoites 
specially in the primary immunizing doses and at challenge. 
Regarding the nature of the observed interference of EEF development, some 
preliminary findings were reported. Circum sporozoite precipitins were readily 
observed in sera of rats and mice, immunized with non-attenuated sporozoites. 
Sporozoite neutralization activity could also be demonstrated (see section 
4.4.1). 
The induction of complete protection appeared to be thymus dependent, as in-
dicated by our failure to induce protection in athymic mice (see section 
4.4.3). These results are in line with those of Spitalny who found the same 
to be true in thymectomized mice (38). 
In not reported attempts to perform in vitro lymphocyte transformation of 
spleen cells from immune rats with cleaned sporozoite suspensions and non 
infected salivary gland suspensions, we only found stimulation with the 
latter antigen. Purified and sterile antigens should be used, prepared by 
the technique described by Krettli and Nussenzweig (39). 
In a small experiment spleen cells from an immunized donor rat were trans-
ferred to normal inbred recipients (see section 4.4.4). After challenge of 
these recipients a considerable reduction of EEF numbers were found. This 
approach gave no clear information about the type of immunogenic cells taking 
part in the anti-sporozoite immune response and previous suggestions of T-cell 
dependency are premature (40). However, nobody has reported, as yet, the in-
duction of protection by cell transfers and this preliminary result indicates 
that our EEF counting method can act as a tool for the measurement of the anti-
sporozoite response in transfer experiments with classified populations of 
immune cells, and with immune sera. 
Though Nussenzweig was unable to transfer immunity with macrophages from the 
liver and the peritoneal cavity, we obtained preliminary evidence that 
macrophages play a significiant role in the arrest of sporozoites. We recently 
found that opsonized sporozoites seem to be more readily phagocytosed by 
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peritoneal macrophages than sporozoites, incubated in normal serum; macro-
phages from sporozoite-immune mice appear the most active in this respect. 
Finally we wish to discuss the possible non-specific effects of mosquito 
debris, that contaminates the sporozoite suspensions. We tried to study these 
effects as reported in section 4.1, exp. 7. Generally, no reducing effect of 
immunization by non-infected salivary gland suspension could be demonstrated 
on the number of EEF after challenge. These results confirm those of Nussenzweig 
(26). She and her coworker Rivera-Ortiz, in fact, demonstrated some increase 
in phagocytic activity and spleen weight after inoculation with suspensions of 
non-infected salivary glands. 
Repeated inoculations induced no potentiation of this mononuclear phagocytic 
activity. Each time the phagocytic activity decreased to normal values after 
a short optimum on the second day. 
Theseresults permitted us to use normal rats as controls, without simultaneous 
iimunization with non-infected salivary glands in each separate experiment. 
However, by loading the immune mechanisms with repeated intravenous inocula-
tions of triturated thoraces of non-infected mosquitoes, we found a signifi-
cant reduction of EEF when these animals were challenged with triturated 
thoraces of infected mosquitoes. The numbers by no means approached the zero-
level and these results are thus quite contrary to those of Alger et al. (41), 
who reported complete protection in half of the treated mice after immuniza-
tion with salivary gland material via the intraperitoneal route. Russell and 
colleagues, (42) who were the first to immunize with sporozoites, using ground 
infected thoraces and challenged via the bite of infected mosquitoes. We suppose 
that at least part of the described responses was due to a non-specific effect 
caused by the repeated inoculation of an equivalent of 200 mosquito thoraces. 
In conclusion we have strong indications that a stage-specific immune response 
underlies the phenomenon of complete and incomplete reduction of developing 
EEF after challenge of rodents that previously had been immunized with suspen-
sions of viable sporozoites (43). The effect of simultaneous immunization with 
debris in the inocula appears to be insignificant, though it is not completely 
excluded. 
5.4 Interference by one previous sporozoite inoculation 
In a series of experiments (see section 4.2) we demonstrated that a consider-
able part of sporozoites inoculated shortly after one preceding inoculation 
is inhibited in the course of their further development. In animals with 
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parasitized liver parenchymal cells newly introducod sporozoites give rise 
to less EEF compared with controls. This phenomenon has not been described 
before, nor is it understood. In our opinion, there is no question of a true 
immune mechanism in the sense of a specific cellular or humoral response. The 
tine period of less than 48 hours seems too short for the induction and imple-
mentation of such a response, 
There are two approaches of attack: the sporozoites before they invade paren-
chymal cells, and the early phase of intracellular EEF development. An effect 
that might interfere with the extracellular sporozoites, could be the non 
specific stimulation of the mononuclear phagocytic system. Rivera-Ortiz and 
Nussenzweig (26) demonstrated that phagocytosis could be stimulated by intra-
venous inoculation of salivary gland suspensions with and without X-irradiated 
sporozoites. 
The effect was measured by changes in spleen weight and by clearance of 
colloid carbon. Both spleen weight and clearance rates showed a rapid in-
crease within 24 hours, and a peak at 2 days after inoculation. Thereafter 
the reactions gradually returned to normal values. They noted that maxi-
mal clearance rates and spleen weights were consistently lower in animals in-
oculated with the non-infected salivary glands. Indications can be derived 
from their results that carbon clearance increases two fold, two days after 
salivary gland inoculation, and an eight-fold increase was found two days 
after inoculation with infected salivary glans, as compared with control values. 
We were not able to demonstrate a significant difference in numbers of EEF when 
the inoculation was preceded 24 hours earlier by an inoculation with non-
infected salivary glands. In the light of the above results it may be that the 
slight increase in phagocytic activity induced by non-infected salivary glands 
after one day is not refelected by change in EEF numbers. The considerable in-
crease in this activity after administration of infected salivary glands may 
correlate with our findings of a more than two-fold reduction of EEF numbers. 
However, we must bear in mind that the host systems were different. 
We observed that when the reinoculation was given 60 hours after the first 
one, the reduction of EEF numbers was more pronounced than after - 24 hours. 
This might be correlated with the cellular reactions at the time of libera-
tion of the merozoites originating from the first infection (- 48 hours). 
Sporozoites that enter the liver might be phagocytosed at higher rates by the 
polymorphs and macrophages, that have been mobilized and are engaged in the 
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engulfenent of merozoites. Spororoites that are inoculated before the rup­
ture of parasitized parenchymal cells do not meet these infiltrates and the 
risk of being phagocytosed before entering parenchymal cells is less pro­
nounced . 
The other mechanism that is seriously considered, has also been suggested by 
Nussenzweig's work. She has demonstrated that pre-erythrocytic stages are 
susceptible to interferons (44, 45). When these agents are induced by a virus 
or otherwise, either non or delayed parasitaemias are observed (46). The 
peak interference was demonstrated when interferon production was induced 24 
hours after inoculation of sporozoites (47, 48). This means that interferon 
influences the EEF development; no retarded EDF have been observed, but at 
that time the parasites are rather small for detection in histological sec­
tions . 
To explain our findings of short term interference, we wondered if the para­
site itself could induce the production of interferon in its host. It had 
been claimed that blood stages of Γ. bernhei are able to do so (49). The re­
sults of our preliminary attempts to demonstrate circulating interferon (see 
section 4.4.2) were successful in rats that had received the artificial in­
terferon-inducer rI:rC. However, the results in rats inoculated with sporo­
zoites were not consistent. Only in one out of three animals a reduction of 
plaque-forming units was demonstrated after 48 hours, thus coinciding with 
the liberation of merozoites and the immediate cellular reactions in the 
liver. Further research is in progress along these lines. 
Thus the results of this series of experiments point to a certain phenomenon 
of interference, the nature of which still waits elucidation. Theoretically, 
the production of a chalón, specific for FEF could also offer an explanation 
for these observations (50), though the occurrence of such agents produced 
by dividing cells and regulating subsequent multiplication is unknown in 
malaria. 
5.5 Interference by present and past parasitaemia. 
As reported in section 4.3, sporozoites inoculated during a primary parasit-
aemia succeeded, to a lesser extent, in developing into EEF than in animals 
without experience of a parasitaemia. In 8 out of 23 rats in the acute stage 
of the infection (section 4.3, exp. 1-3) no liver schizonts could be detected 
at all. 
In animals with lowered parasite densities and in animals immunized with 
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erythrocytic stages mean nunbers of EEF were below that of controls (exp. 
4-6). Though further experimental data are needed to confirm and extend 
these findings, this phenomenon of interference has never been described be-
fore. To our knowledge, only Yoeli has published some results on sporozoite 
infections, following parasitaemias in rats. Shortly after his discovery of 
the optimal conditions of sporozoite induced infections (51, 52, 53) he tried 
to discern if sporozoites could develop into EEF in rats immune to erythro-
cytic stages (3, 34). Maturing EEF were found in such animals, but no sub-
sequent parasitaemia could be detected. He stated that acquired immunity to 
sporozoite or trophozoite induced parasitaemias is not extended to sporo-
zoites. The only mechanism involved is, what was called the hemo-hepatic 
barrier. This liver-blood barrier would prevent merozoites originating from 
EEF penetrating erythrocytes. Our results confirmed the effectiveness 
of the liver-blood barrier, since animals immune to erythrocytic stages, need 
no protection with chloroquine during a subsequent immunization with sporo-
zoites. 
Bafort (9) has also published observations on the influence of previous para-
sitaemias on sporozoites. In two thicket rats that had survived a sporozoite-
induced (?) parasitaemia of P. winckei, the acquired immune response was 
repeatedly boosted with erythrocytic stages. After a subsequent sporozoite 
inoculation no EEF were found in 50 serial sections of a liver biopsy. After 
a further sporozoite inoculation via mosquito bites EEF could also not be 
detected. It remained unclear whether this result was due to a nonspecific, 
or to a species- or stage specific response. But it seems to contrast with 
the findings of Yoeli. The immune response to the erythrocytic stages ap-
parently prevented the development of EEF, whereby the induced liver-blood 
barrier was not challenged. 
Our results are intermediate between those of Yoeli and Bafort. The general 
statement of Yoeli that in bloodstage-immune animals sporozoites are able to 
develop into EEF was confirmed, however, with one important restriction. We 
found a significant, two-fold reduction in the number of EEF. 
As was stated before, Garnham (1, 2) found EEF after reinoculation with 
sporozoites in monkeys that had previously developed a sporozoite induced 
parasitaemia of P. aynomolgi. Similar results were claimed for P. vivax (54) 
and P. malaviae (55) and it was stated that the strong immunity against the 
blood forms of the homologous strain was completely without influence on the 
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EEF. 
We confirm that if there is EEF development, their shape is not different 
from that in animals without such inmunity. Since antibodies are not able to 
gain access to the intracellular parasites, this is to be expected. 
But before the entry of host cells, sporozoites are vulnerable and somehow 
the number of EEF may be reduced. 
This is, however, difficult to demonstrate in experiments with primate malar-
ias, since inclusion of the required controls for the demonstration of re-
duction is sometimes an unattainable luxury. 
We feel, therefore, that the conclusions of these authors should be recon-
sidered in the light of Nussenzweig's findings in mice and primates, and our 
results with rodents. 
As to the explanation of interference of present and past parasi taenias, 
there are some mechanisms that are worth considerinß. 
a) Сг оиІаЬгпд interferon. 
Nussenzweig presented evidence that pre-erythrocytic stages of P. berghei 
are susceptible to interferon (44-47). At the same time Huang et al.(49) 
found that during a parasitaemia of P. berghei serum titres of interferon 
were increased, and that, on the other hand, the onset of parasitaemia could 
be delayed with interferon (56). Others could not confirm this effect in 
human malaria (57). In a preliminary attempt we were also unable to show 
demonstrable interferon production in rats with a trophozoite-induced parasit­
aemia. 
b) Interstage cross-reaeting antibodies. 
It has been demonstrated that sporozoites and EEF'react in fluorescent anti­
body tests with sera from animals with a parasitaemia, and vice versa (58-62). 
As has been stated, a functional cross-protection is unlikely (63). 
c) Soluble antigen-antibody complexes. 
During a parasitaemia soluble antigen-antibody complexes are circulating (58). 
These complexes, involved in the pathophysiology of malaria, activate the 
complement system. It should be considered that soluble antigens or complexes 
possibly may adhere to sporozoites. Thus burdened sporozoites may then be 
readily phagocytosed, especially through the interaction of complement factors; 
other activated complement components may cause lysis of sporozoites. 
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d) Inareane of yhanoeytic activitij. 
There is a considerable evidence that colloid carbon is cleared faster in 
aniñáis with a parasitaemia, directly after its onset; results of several 
other approaches have also pointed to the involvement of the mononuclear 
phagocyte system (65-70). The number of macrophages in the liver increases 
rapidly and Kupffer cells can be observed loaded with plasniodial pigment. 
Kupffer cells and other macrophages lining blood sinuses, that are thought to 
remove sporozoites of a primary inoculation, might be activated by Τ lympho­
cytes that are specifically stimulated during parasitaemia. We previously 
found indications for stimulation of Τ cells in monkeys and mice after blood-
borne infections (71, 72). Evidence for Τ cell-induced nonspecific activa­
tion of phagocytosis and intracellular killing in macrophages of other para­
sites is growing (73, 74). 
e) Hepatic dys junation. 
In a review on liver involvement in acute mammalian malaria, Maegraith (75) 
pointed to several pathogenic effects. Acute P. berghei parasitaemia causes 
lesions in the livers of rodents; sinusoids are dilated and congested; large 
numbers of swollen Kupffer cells are present and the intrahepatic blood-
flow is reduced; glycogen disappears from parenchymal cells, mitochondria 
are damaged and a fatty degeneration of these cells is apparent. Since paren­
chymal cells are the sites of multiplication of pre-erythrocytic stages, the 
considerable reduction of EKF during parasitaemias might be explained by a 
deterioration of the environment. Another report (12) points towards the in­
ability of sporozoites to develop into EEF and subsequent parasitaemia, in an 
ethionine-induced fatty liver. Thus by deposition of fat, the capacity of 
degenerating parenchymal cells to support intracellular growth of EEF might be 
affected. The diminished number of maturing EEF after a sporozoite inoculation 
during a parasitaemia, might be caused by a combined action of more than one 
of the above mentioned mechanisms. The described results could only be obtained 
through the use of the quantitative method to determine relative EEF-densities. 
5.6 Epidemiological considerations on anti-sporozoite responses 
There appears to be no question of a total protective response to sporozoites 
in nature. People in endemic areas are regularly exposed to infected mosquitoes, 
and they show parasitaemias, which not likely originate only from relapses. To 
our knowledge serious attempts to demonstrate the occurence of natural 
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sporozoite specific antibodies in man have never been performed. 
This nay be due to obvious difficulties, such as the problem to obtain mos-
quitoes, infected with human plasmodia, for the preparation of sporozoite 
antigen required for the serological test, and thp problems of crossreactivity 
in the fluorescent antibody test with antibodies induced by the erythrocytic 
stages. Moreover, the non-pathop.enic pre-erythrocytic stages have always re-
cieved little attention, especially as sporozoites are repeatedly said not to be 
irmunop.enic. 
However, since the describing, by Vanderberg and his coworkers (76), of a pre-
cipitate forminR at one end of sporozoites placed in serum from immunized 
rodents, a specific in vitro anti-sporozoite test has been available. Applying 
this test, CSP activity was demonstrated in a wild-caught monkey (77). In the 
serum of monkeys and volunteers immunized with irradiated sporozoites such 
precipitins could also be demonstrated but they only occur after several large 
boosters. The experimentally induced protection and the detectability of anti-
bodies lasts in vaccinated primates at least for months. The apparent diffi-
culties to induce protective anti-sporozoite responses in monkeys and men and 
the requirement of considerable numbersof sporozoites might reflect why the na-
tural response to mosquito-borne sporozoites is not effective at first sight. 
When we would succeed in developing a method for detection of antisporozoite 
antibodies in man, and assuming that antibodies attribute to neutralization 
under natural circumstances in endemic malarious areas, then a wide area is 
open for studies of great practical importance. 
In areas with season dependent transmission the period of effective antisporo-
zoite immunity should then be determined. And when a natural response exists, 
but would be not sufficient to bridge the transmission periods, the question 
* . ... 
would arise, whether the natural response can be potentiated artificially. 
Such attempts to increase the natural response by sporozoite vaccines would 
then certainly also be applicable in areas with a constant pattern of trans-
mission. For this kind of vaccination the infants and youngsters should be 
considered in the first place. We should keep in mind, however, that vaccination 
remains an idle dream as long as there are no methods for in vitro cultivation 
of parasites. 
If we extrapolate the findings of our experimental study to the situation in 
the field, then the following possibilities should be considered. 
a. Frequent inoculations of sporozoites may cause a response that partially 
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prevents the development of EEF, reducing the number of merozoites entering 
the circulation. 
b. Present and past parasitaemias may also interfere with the invasion of 
liver parenchymal cells by sporozoites. This would also reduce the number of 
generated merozoites. 
Such a reduction of the number of merozoites would mean that reinfection of 
the blood starts with a lower parasite density. This in turn would imply a 
less severe course of the desease and less immuno-pathological damage since 
the amount of soluble antigen remains lower. 
It is a wellknown fact that the partial immunity to erythrocytic stages in 
man is established after years of intensive contact with parasites from the 
local strains. The hypothetical reduction of the frequence whereby merozoites 
initiate parasitaemias might contribute to the explanation of this long term 
phenomenon. 
MacDonald (78) indicated that there is a discrepancy in malaria endemic areas, 
between the inoculation rate assessed by entomological methods and that esti-
mated from the infant parasite rate. The former can be up to hundred times 
higher. It is tentative to suggest a relation with anti-sporozoite responses 
and interference of EEF-development. Gamham (79) has also referred to 
MacDonald, but he considered this discrepancy due to various causes, including 
a diminished exposure, natural racial immunity, the presence of protective 
traits like hemoglobin S, a milk diet and passive immunity inherited from the 
mother. Elsewhere (2), Carnham points to the fact that many of the sporozoites 
transmitted by mosquitoes are non-viable, and though he does not believe in 
the effectiveness of anti-sporozoite responses, he does not exclude the possi-
bility that large numbers of such non-viable sporozoites, constantly intro-
duced into man, provoke an immune response! This he considers to be one of the 
many factors which might contribute to the mildness of the desease in the in-
digenous population of holoendemic localities. 
It is reiterated that, in the human system, only non-protective anti-sporozoite 
antibodies are demonstrable. Even so, the study of anti-sporozoite responses 
in people living in endemic areas deserves serious consideration, and attempts 
to potentiate such responses are, in our opinion, indicated. 
The successful development and application of sporozoite vaccines seems de-
pendent on the understanding of pre-erythrocytic development and the induction 
of immune responses against these stages in the natural hosts. 
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5.7 Suggestions for further research in animal models 
5.7.1 Understanding of the pre-evythrooytia cycle of a primary infection 
and the rtechanisns of innate resistance 
General routes of sporozoites through the circulation might be studied by 
ligation, extirpation and transplantation of organs, especially the liver 
(80) and the spleen. The places or cells that are finally reached by sporo-
zoites, and early development into EEF might be revealed by labeling and 
autoradiography (81), by electron microscopy, and by fluorescence in cryostat 
sections from different organs. It seems tempting to search for lurking sporo-
zoites or cryptic tissue stages in the intestinal tract, since this is the 
predilection place for sporozoites of other Coccidiida. Their discovery any-
where might explain recrudescences in primate malaria and the origin of stages, 
indicated as chronic EEF in tree-rats (82, 83). 
Genetic variation of the host species might influence susceptibility, as 
possibly expressed by different interaction of macrophages and liver paren-
chymal cells with sporozoites. Referring to the studies of Hiller (84) on spe-
cial merozoite receptors on erythrocytes, it should be examined if cell mem-
branes of parenchymal cells contain special receptors for sporozoites. 
Another fact in the innate resistance of unsusceptible hosts might be the in-
sufficiency of parenchymal cells to support EEF development. Requirement of 
certain chemical compounds should be studied (i.e. the beneficial effect of 
methionine has been described (12). 
Innate macrophage-mediated resistance might be studied using anti-macrophage 
serum or phagocytosis-inhibiting chemical agents; the macrophage barrier in 
the liver might be bypassed by exposing parenchymal cells directly to in-
fection through the injection of sporozoites into the bile duct (85). In-
fection of sucklings that have received a transfer of macrophages from syngeneic 
adult donors is also worthy of examination. By these approaches the mechanism of 
increasing resistance with age might also be revealed (85). 
5.7.2 Analysis of the protective anti-sporozoite immune response ( antibody-
mediated reactions ) 
In addition to CSP and SNA reactions other serological methods should be 
applied and developed. Fluorescent antibody techniques, using sporozoites or 
cryostat sections of infected liver might be helpful to study IgM and IgG 
immunoglobulins, and their cross-reactivity with erythrocytic stages. 
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Anti-sporozoite responses in rodents, treated with suppressive or causal 
prophylactic drugs, could be studied. It should also be assessed if trans-
placental transmission of specific anti-sporozoite antibodies occurs, which 
may protect sucklings against infection. The role of various antibodies and 
classes and subclasses of these immunoglobulins should be studied further in 
relation to protection and if possible, the in vivo effects of antibody acti-
vated phagocytosis should be quantified. 
Such techniques might be applied later on in epidemiological studies, to de-
tect anti-sporozoite responses in humans, living in areas of various endemi-
cities. 
5.7.3 Cell-nediated reactions 
Participation of thymus dependent cells in antibody production should be 
elaborated (38). The use of athymic mice, (neonatal) thymectomy, antithymocyte 
serum and immunosuppressuve drugs are recommended, including subsequent re-
constitution with cells of normal sygeneic donors. Specific stimulation of 
thymus dependent lymphocytes might be elucidated by transfer of enriched pop-
ulations of T-cells, of thymocytes or thoracic duct cells from immunized 
donors into syngeneic recipients, and sporozoite-infectivity assessed in 
vivo. In vitro stimulation could be measured in a lymphocyte transformation 
test, using purified sporozoites as antigen (39). Simultaneously the possible 
cooperation of antibodies with cell-mediated mechanisms could be studied. The 
potentials of macrophages in sporozoite and blood stage-immunized hosts, in 
terms of T-cell-mediated activation is worth consideration. Moreover, a sup-
posed role of macrophages in processing the sporozoite antigens and presenting 
them to immunocompetent cells should be investigated. 
The cellular responses to sporozoites might also be studied in avian malaria, 
since birds have a lymphoid organ in which antibody producing B-cells are 
processed ( the bursa of Fabricius). The immune mechanisms may be studied by 
neonatal bursectomy and thymectomy. 
Moreover, the site of intracellular multiplication of EEF in avian Plasmodia 
are the macrophages. In other systems, like Listeria, Leishmania and Toxo-
ptasma, T-cells play a role in the activation of macrophages and the subse-
quent killing of intracellular parasites. It is worth investigating if such 
mechanisms are also active in birds immunized with sporozoites. 
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5.7.A Differences between the proteative responses to -irradiated and viable 
sporozoites 
The timing of induction, boosting and duration of protective and non-protective 
humoral responses, to both irradiated and viable sporozoites should be studied 
further. The contribution of the cellular reactions at rupture of parasitized 
liver parenchymal cells to the anti-sporozoite response is unknown. 
Λ qualitative and quantitative description of these infiltrations before and 
during immunization with viable sporozoites is worth performing. 
The immunogenic properties of degenerate, non-viable sporozoites might give 
information on the contribution of these stages to the immune response, in com­
parison with infective and with attenuated sporozoites. 
Some of these suggestions were already put forward as recommended research sub­
jects in a joint review by ΙΛΕΑ and WHO (86), and several points are presently 
included in the research program at the Institute of Medical Parasitology of 
the Nijmegen University. 
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G L O S S A R Y 
abortive infeation: unsuccessful development inside parasitized cell. 
agglutination: clumping of particulate ag in the presence of ab. 
antibody (ab): protein formed in response to ag and reacting specifi-
cally with it. 
antigen (ag): substance capable of stimulating ab-formation and able 
to react specifically with it. 
attenuation: loss of multiplication potentials (e.g. after irradiation). 
booster: supplementary dose of ag to increase the immunological 
response. 
causal prophylaxis: prevention of plasmodial pre-erythrocytic development. 
challenge: test of immunity by exposure to infective, non-
attenuated ag after specific immunization. 
CSF: circum-sporozoite precipitation. 
EEF: exo-erythrocytic form(s). 
epidemiology: complex of factors determining the incidence of malaria 
in the field. 
exo-erythrocytic: plasmodial stage developing inside liver parenchymal cell 
(mammalian). 
immune: state of being protected against infection. 
immunization: repeated administration of ag, to make the animal immune. 
infectivity: parasite-host inter-relationship, permitting invasion and 
intracellular multiplication. 
interferon: protein produced by cells after uptake of virus or Proto-
zoon suppressing growth of same or different organisms in 
other cells. 
Kupffer cell: fixed macrophage in the liver. 
lymphocyte: either antibody producing, (B) or thymus-dependent (T) 
small cell in circulation or lymphoid organs. 
macrophage: mononuclear phagocyte. 
merozoite: product of plasmodial segmentation of a tissue (EEF) or 
erythrocytic schizont. 
oocyst: fertilized plasmodial cell after encystment on mosquito 
stomach,and producing sporozoites. 
parasitaemia: condition in which erythrocytic stages are present in 
the blood. 
phagocytes: circulating or tissue cells, capable of engulfing and 
destructing foreign material. 
pre-erythrocytic: plasmodial stages from inoculation with sporozoites to 
liberation of merozoites from the liver. 
prepatent period: time lapse between inoculation of sporozoites or erythro-
cytic stages and the detectable onset of parasitaemia. 
SNA: sporozoite neutralization activity. 
sporozoite: plasmodial stage produced in oocyst and occurring in sa-
livary glands of mosquito; transferred to vertebrate host 
while biting. 
trophozoite: erythrocytic form in its early stage of development. 
vaccine: suspension of dead or living (attenuated) organisms, in-
jected to establish resistance to the disease. 
viability: condition of the parasite, being intact, mobile, healthy, 
and supposedly capable of multiplication. 
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S U M M A R Y 
Information on immunogenicity of plasmodial sporozoites comes mainly from 
work with attenuated parasites. In this study we were able to demonstrate 
that viable sporozoites of Plasmodium berghei cause also an immune response 
in mice and rats, which may last for months. The effectiveness of this re-
sponse increases with the number of sporozoite-inoculations and may cause 
prevention of exo-erythrocytic development on challenge. The response becomes 
completely protective and parasitaemias don't develop. 
The mechanism of this response is not clear. Anti-sporozoite antibodies are 
demonstrable, and activity of the mononuclear phagocyte system may also be 
involved. The role of these phenomena in protection is not established, but 
it was found that thymocytes are required for the generation of a protective 
response. 
The density of exo-erythrocytic forms (EEF) in the liver is taken as a measure 
of the number of infective sporozoites escaping natural and acquired mecha-
nisms of resistance. Animals are kept on chloroquine during immunization, to 
ensure that the immune responses to parasitaemia don't interfere with anti-
sporozoite immunity. We found that sporozoites inoculated during the acute 
stage of parasitaemia give rise to considerably fewer EEF. The density of EEF 
is also considerably reduced in animals that are immune to erythrocytic stages. 
This effect is probably non-specific. 
Another type of interference of EEF development becomes evident when a second 
inoculation of sporozoites is given within the 48 hours of EEF maturation 
after the first inoculation. This reduction of development of second set EEF 
probably has a non-immunological background. 
The findings of this study may be useful for an insight into unexplained 
epidemiological phenomena, and the investigation of the possibility of poten-
tiating any naturally occurring anti-sporozoite response is suggested. More-
over, the development and application of sporozoite vaccines is dependent 
upon the understanding of anti-sporozoite responses. We are only at the be-
ginning of the exploration of the host's reactions to the presence of pre-
erythrocytic stages of the malaria parasite. 
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S A M E N V A T T I N G 
In de gecompliceerde levenscyclus van de malaria-parasiet is alleen het 
stadium in de rode bloedcellen pathogeen. Onderzoek naar de immunogenici-
teit heeft zich dan ook voornamelijk op deze vormen van de parasiet ge-
richt. Andere stadia leken geen immunologisch verweer op te roepen; met 
name sporozoieten die overgebracht worden door muggen, werden beschouwd als 
niet immunogeen, omdat ze ofwel te kort in de circulatie zouden blijven, 
ofwel in te kleine aantallen toegediend zouden worden. In hoofdstuk I hebben 
we de beschikbare literatuur gegevens gerangschikt. 
Door het werk van Nussenzweig, die bestraalde sporozoieten inspoot, bleek 
dat er wel een duidelijk verweer wordt opgebouwd tegen dit stadium, waarbij 
de dieren na herhaald contact met deze verzwakte sporozoieten immuun worden. 
Ze zijn beschermd tegen infectie met infectieuze sporozoieten. 
Onze interesse ging in de richting van een meer natuurlijke benadering. 
We hebben onderzocht hoe de gastheer (rat) reageert op herhaald contact met 
infectieuze sporozoieten (Plasmodium berghei). Om dat te meten hebben wij 
een tel-methode ontwikkeld, waarmee relatieve dichtheden van parasieten in 
de lever werden bepaald. In the parenchym cellen van de lever ontwikkelen 
zich exo-erythrocytaire vormen (EEF) uit sporozoieten. Na veelvuldige deling 
produceren deze EEF de erythrocytaire stadia, waarmee de parasitaemia begint. 
In ons onderzoek hebben we die erythrocytaire stadia tijdens de immunizatie-
procedure onderdrukt met een anti-malaria middel dat niet op de preerythro-
cytaire stadia werkt (chloroquine). 
Hoofdstuk II beschrijft de techniek en methoden die werden toegepast. 
Hoofdstuk III is gewijd aan een statistische verantwoording van de tel-
methode en we hebben aangegeven op welke wijzen deze methode toepasbaar is 
in allerlei onderzoek naar de pre-erythrocytaire parasiet-gastheer verhouding. 
In sektie 4.1 van hoofdstuk IV, hebben we de experimenten beschreven waarbij 
de gastheer meermalen sporozoieten kreeg toegediend. We vonden dat de dieren 
hierdoor beschermd konden worden tegen hernieuwde infecties met sporozoieten. 
Minder intensief contact met sporozoieten leidt wel tot aanzienlijke ver-
mindering van het aantal EEF in de lever, maar niet altijd tot preventie van 
latere EEF-ontwikkeling. Het effect blijft maanden lang meetbaar. 
In sektie 4.2 is het verschijnsel beschreven dat een tweede dosis sporo-
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zoieten, toegediend binnen 48 uur na een eerste dosis, resulteert in lagere 
parasieten-dichtheden dan in dieren voor welke die tweede dosis de eerste 
was. Een poging om aan te tonen dat interferon, geproduceerd na de eerste 
infectie, hiervan de oorzaak is, had geen duidelijk positief resultaat. 
In sectie 4.3 staan de experimenten beschreven die betrekking hebben op de 
invloed van parasitaemieën op de dichtheid van EEF na inoculatie met sporo-
zoieten. Ook hier werd een duidelijke remming aangetoond. 
In sectie 4.4 zijn enkele losse experimenten beschreven, die waren opgezet 
om het werkingsmechanisme van de beschermende immuun response te bestuderen. 
Verschillende typen van anti-sporozoieten-antistoffen blijken aanwezig in 
immune dieren, noch Chloroquine behandeling, noch parasitaemieën lukten 
daarop een duidelijk effect. 
In de discussie (hoofdstuk V) is ingegaan op de betekenis van deze bevindingen. 
Het is door dit onderzoek duidelijk geworden, dat sporozoieten niet verzwakt 
behoeven te worden om een immuun response te veroorzaken. Verrassend waren de 
vondsten dat pre-erythrocytaire vormen en erythrocytaire vormen kunnen inter-
fereren met de infectiositeit van sporozoieten. 
Het is onjuist om resultaten in een knaagdier model van toepassing te ver-
klaren op het humane model. Toch hebben we gemeend te moeten overwegen wat 
een anti-sporozoieten verweer kan betekenen voor mensen die regelmatig door 
geïnfecteerde muggen gestoken worden, en voor de epidemiologie van malaria. 
Het lijkt de moeite waard om onderzoek te beginnen naar dit specifieke ver-
weer bij mensen in endemische gebieden. 
Tenslotte is aangegeven welke lijnen van onderzoek in het dier model nu voor 
de hand liggen. 
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S T E L L I N С Π Ν 
Ι. 
Protectieve innuniteit tegen sporozoieten lijkt bepaald te worden door 
opsoniserende antistoffen uit de IRG klasse, welke zonder de hulp van 
thymus-afhankelijke lymfocyten niet worden aangemaakt. 
Brown (1974), Antigenic variation and 
innunity to malaria. In "Parasites in the 
innunized host, mechanisms of survival". 
СІІ5Л Found.Symp. 25 
II. 
Het is waarschijnlijk dat infectieuze sporozoieten minder bijdragen tot 
het sporozoiet-specifieke verweer dan niet-infectieuze sporozoieten; de 
antigenen die vrij konen na voltooiing van de intracellulaire ontwikkeling 
in de lever kunnen hierbij echter wel van belang zijn. 
Dit proefschrift. 
III. 
Er zijn aanwijzingen dat lever parenchym cellen de capaciteit tot endocytose 
hebben; dit maakt het aannemelijk dat ze actief betrokken zijn bij het 
"binnendringen" van sporozoieten. 
Kief et al. (1974), Endocytotic functions 
of Kupffer and liver cells. In "Activation 
of macrophages". (Eds. Wagner & llahn) 
IV. 
Immunodepressie tijdens het acute stadium van de malaria-parasitaenie be­
gunstigt de vermeerdering van andere microörganismen, maar niet de ontwik-
keling van homologe sporozoieten. 
Dit proefschrift. 
V. 
Bij sporozoieten-infecties van naakte, thyrausloze muizen dient rekening te 
worden gehouden met veminderde aantallen exo-erythrocytaire vormen, door de 
levernecrose, die deze dieren vaak vertonen. 
VI. 
De mate waarin een geschikt gebleken diersoort wordt geëxploiteerd ten be-
hoeve van bio-medisch onderzoek, creëert een markt waarvoor het natuurlijk 
reservoir niet toereikend is. Zo dienen ten behoeve van malaria onderzoek 
bestaande alternatieven voor de in het v/ild gevangen dourocouli's uitgewerkt 
en gefinancierd te worden. 
VII. 
Bij de bestrijding van overbrengers van malaria en andere ziekteverwekkers 
dringt zich de noodzaak op, toepassing van persistente insecticiden te inte-
greren met biologische en genetische methoden. Voor evaluatie van de ver-
schillende benaderingswijzen verdient het oecologisch onderzoek een hogere 
prioriteit. 
WHO Techn. Rep. 561 (1975), Ecology and con-
trol of vectors in public health. 
Wetenschap en Samenleving 75/2 
VIII. 
Voor inzicht in de transmissie van parasieten door geleedpotigen is kennis 
van huid- en lymfeklierreacties op de orale secretie van belang; daarbij 
doet het minder ter zake of de betreffende antigenen uit het speeksel of van 
concomitante microörgtinismen afkomstig zijn. 
IX. 
De suggestie dat Acanthamoeba polyphaga chronische cornea zweren kan ver-
oorzaken, steunt niet op onderzoek, waarin wordt aangetoond dat aan de postu-
laten van Koch is voldaan. Het is dus niet terecht reeds te spreken over een 
"Amoebic infection of the eye". 
Nagington et al. (1974) Lancet 2^,1537. 
Χ. 
Premunitie speelt geen rol van betekenis in het verweer tegen experimentele 
herinfectie van de hond met mijnworm-larven. 
XI. 
De associatie van Pneumocystis infecties bij de nens net virale infecties 
in de longen, en de recente bevindingen van een dergelijk samengaan in ratte-
longen, naakt waarschijnlijk dat dit microorganisne een saprofytische levens-
wijze heeft en tot opportunistische infecties kan leiden. 
XII. 
Malaria onderzoek door de Amerikanen, tijdens de afgelopen oorlog in Z.O.-
Azië, weerspiegelde allerminst de goede bedoeling van de interventie voor de 
inheemse bevolking. 
XIII. 
Voor inperking van de zilvermeeuwen-populatie in het Nederlandse Waddengebied, 
zo die al zou moeten plaats vinden, is het rapen van eieren geen effectief 
middel. 
XIV. 
Het advies van de Rijksdienst voor de Tlonumentenzorg om bij restauratie van 
e e 
de 14 eeuwse kerk te lleumen alle 19 eeuwse, gietijzeren ramen te handhaven, 
is op historische en estetische gronden aanvechtbaar; met name in het schip 
zouden ze naar oude vorm hersteld dienen te worden. 
XV. 
De aanspraken van thans in leven zijnde leden van de fanil ie Verhave op het 
familiewapen van het geslacht Verhaven zijn ongegrond. 
XVI. 
De Duif in het blazoen van de Katholieke Universiteit herinnert aan rijke 
beloften. De tijd is rijp om te woekeren met charismatische talenten. 
Malden, augustus 1975. 


